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 In an environment with limited resources, organisms employ a variety of offensive and 
defensive mechanisms to ensure their own survival and growth. Many organisms utilize 
ribotoxins to respond to cellular stress or to kill competing organisms. Ribotoxins are site-
specific endonucleases which typically target RNA molecules that are necessary for translation 
mainly, tRNAs and rRNAs which can result in their loss of function. In order to respond to RNA 
damage, some organisms have developed RNA repair systems which can heal and seal the 
cleaved RNA molecule to restore its function. For example, two proteins in bacteriophage T4, 
PnkP and Rnl, have been shown to reverse tRNA damage caused by its host’s stress response. In 
bacteria, numerous RNA repair systems have been identified by bioinformatics and biochemical 
studies; however, the in vivo targets of these systems have been difficult to identify.  
 RNA repair systems repair systems are highly diverse but are generally composed of an 
RNA ligase and several processing and scaffold proteins. One family of RNA ligases, RtcB, is 
widely distributed among the domains of life and has been implicated in tRNA splicing in 
eukaryotes and archaea. However, the role of RtcB in bacteria remains elusive. Bacterial RtcB 
may be involved in RNA repair but the complexity of RNA damage and repair within the cell 
make it difficult to identify the in vivo targets of a particular RNA repair system. Instead, our lab 
has chosen to study proteins that are frequently found to be associated with RtcB in order to 
learn about RtcB itself. One such protein which has been found to be in many diverse RNA 
repair operons, including many containing RtcB, is RlaP-NTase (RNA Ligase-associated Polβ). 
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 RlaP-NTase is a novel nucleotidyltransferase (NTase) of the Polβ superfamily. NTases 
are known to transfer NMP from an (d)NTP onto an acceptor molecule, such as an RNA, DNA, 
protein, or small molecule. The Polβ superfamily is very large and highly diverse family which 
carries out many important biological functions including tRNA and mRNA maturation, DNA 
repair, cell signaling, and innate immune response. Due to its association with RtcB and its likely 
NMP transfer activity, we hypothesized that RlaP-NTase be involved in cellular response to 
“smart” ribotoxins which not only cleave RNA but also remove one or two nucleotides from the 
damaged ends.  
 In order to study RlaP-NTase, we chose to clone and purify recombinant RlaP-NTase 
from two organisms, pseudomonas fluorescens and pseudomonas aeruginosa. Biochemical 
studies of these two enzymes have shown that RNAs, not DNAs or proteins, are substrates for 
RlaP-NTase. Additionally, in vitro assays employing two synthetic RNA molecules revealed that 
RlaP-NTase catalyzes the addition of one or two NMP molecules onto the 3’-OH group of its 
RNA substrate and that the reaction exhibits a preference for RNA substrates resulting from 
damage by ribotoxins. Interestingly, RlaP-NTase preferred to utilize Mn+2 as a metal cofactor for 
coordinating NTP whereas most known NTases use Mg+2.  
 Structural studies of PfRlaP-NTase have also been carried out. The structure of PfRlaP-
NTase was revealed to be an N-terminal NTase motif fused to a C-terminal helical domain. The 
N-terminal and C-terminal domains come together to form a cleft where NTP and RNA substrate 
bind. The NTase fold contains catalytic aspartic acid residues positioned to coordinate NTP. 
Furthermore, based on the results of our in vitro reconstitution assays, we carried out preliminary 
functional studies of PfRlaP-NTase. Aminoacylation assays indicated that RlaP-NTase is 
necessary to restore biological function to repaired tRNAs that have experienced loss of a single 
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nucleotide.  While this study was not conclusive, it is consistent with our hypothesis that RlaP-
NTase acts to restore nucleotides removed by “smart” ribotoxins prior to RNA repair resulting in 
a functional RNA once ligated.   
 In addition to studying RNA repair, our lab is interested in studying the purposeful 
damage of RNA carried out by ribotoxins. Though bioinformatics has identified many new 
ribotoxin families present in all major bacterial lineages, only a handful of ribotoxins have been 
thoroughly characterized. Previous work in our lab has involved cloning many of these 
uncharacterized ribotoxins and testing them for toxicity in vivo. One novel ribotoxin which was 
shown to be highly toxic was Pa-CD (pseudomonas aeruginosa colicin D-like). RNA-seq assays 
performed in our lab determined that Pa-CD cleaves four isoaccepting tRNAs between bases 38 
and 39 in the anticodon loop. I have cloned and overexpressed Pa-CD in complex with its 
immunity protein, Pa-CD Immunity and separated the tightly bound proteins. I performed 
biochemical assays to confirm the target of Pa-CD in vitro and carried out structural studies of 
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CHAPTER 1: INTRODUCTION TO RNA DAMAGE AND REPAIR AND THE NTASE 
SUPERFAMILY 
 
1.1 RNA Damage 
RNA Cleavage in cells  
 In an environment with limited resources, organisms must employ a variety of offensive 
and defensive mechanisms to ensure their own growth and survival. One of the most prevalent 
and efficient means of ensuring self-survival is through the utilization of ribotoxins. Ribotoxins 
are endonucleases which cleave RNA molecules in a site-specific manner. The RNA backbone 
can be broken by the nucleophilic attack of the 2’-OH group on the neighboring 3’-phosphate 
resulting in breakage of the phosphodiester bond (Figure 1.1)(1). RNA cleavage can occur via 
either normal cellular processes such as tRNA and mRNA splicing and RNA metabolism or by 
targeted cleavage by ribotoxins. RNA damage will henceforth refer to the site-specific cleavage 
of the RNA backbone by ribotoxins. 
Overview of ribotoxins 
 Most known ribotoxins target RNAs that are necessary for translation- tRNAs, mRNAs, 
and rRNAs. A summary of known ribotoxin targets is shown in Figure 1.2. The most commonly 
targeted sites are those which play integral roles in protein translation: the anticodon loop of a 
tRNA (2,3), helix 44 of the 16S rRNA of the small ribosomal subunit (4) and the sarcin-ricin 
loop (SRL) of the 23 rRNA in the large ribosomal subunit (5,6). The anticodon loop of a tRNA 
plays a critical role in recognition by its cognate aminoacyl-tRNA synthetase and decoding of the 
mRNA codon (7,8). Helix 44 is found in the A site of the ribosome and is involved in decoding 
and translation fidelity (8,9). The SRL has been shown to be important for the binding of the EF-
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Tu·GTP·tRNA ternary complex to the ribosome and its interaction with EF-G is necessary for 
translocation (10,11). Damage at these three sites impedes translation. Many organisms have 
evolved to use ribotoxins to exploit the importance of these crucial RNAs in order to kill 
competing organisms or for self-restriction during a period of cellular stress to conserve 
resources (10,12,13).  
 Bacteria frequently utilize ribotoxins in order to restrict growth of competing bacteria or 
to evade their host’s defense mechanisms. A widespread network of secreted toxins and their 
associated proteins called polymorphic toxin systems (PTS) has been identified in every known 
major bacterial lineage (14). PTSs consist of a multidomain toxin in which the N-terminal 
domain is involved in secretion and the C-terminal region contains a toxin domain that can act as 
an RNase, DNase, or protein-modifying enzyme. Additionally, PTS loci contain genes which 
code for immunity proteins that provide protection against the toxin for the cell producing it. The 
most extensively studied group of PTSs are colicins which are produced by Escherichia coli. 
Colicins are modular multidomain proteins with an N-terminal translocation domain, a C-
terminal toxin domain, and a central receptor binding domain (15). Many colicins have RNase 
activity which targets either rRNA or tRNA. Colicin E3 targets helix 44 of the 16S rRNA (4). 
Colicin E5 specifically cleaves four tRNAs which contain queuine at their wobble position 
between bases 34 and 35 (Figure 1.3, upper panel)(16). Colicin D cleaves four isoaccepting 
tRNAsArg between bases 38 and 39 (Figure 1.3, lower panel)(3).   
 Other PTS families have been identified in bacteria. Toxin-antitoxin (TA) systems in 
bacteria have been linked to persistence and dormancy which promote drug and antibiotic 
resistance (17-19). Under normal conditions, the cell expresses both the toxin and antitoxin 
components. When under stress, the antitoxin is degraded, leaving the toxin to carry out its toxic 
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activity which leads to inhibition of translation, arrest of cell growth, and dormancy (20,21). The 
most common TA family is vapBC (virulence associated protein, B=antitoxin, C=toxin) (22). 
VapC toxins contain PIN (pilT amino-terminal) domains which are endoribonuclease domains 
that are involved in RNA metabolism in eukaryotes (23). Mycobacterium tuberculosis is the 
deadliest human bacterial pathogen and exhibits a high degree of persistence (24). M. 
tuberculosis contains more than 88 TA system loci of which more than half are vapBC. Due to 
the prevalence of these loci and the fact that vapBC loci have been found to be associated with 
virulence and pathogenicity factors, many researchers believe that vapBC systems may be linked 
to persistence and drug resistance (25). Many members of the VapC family have been shown to 
inhibit translation through tRNase activity (26,27). Two VapCs, VapC20 and VapC26, have been 
shown to cleave the SRL in the 23S rRNA (5,27). TA systems were found to be upregulated in 
persistent E. coli and M. tuberculosis cells (19,28). The addition of chloramphenicol to E. coli 
cells carrying vapBC plasmid increased vapBC transcription and induced VapC activity (26). 
This data suggests that TA systems such as vapBC play an important role in persistence and drug 
resistance through the inhibition of translation and cell growth.  
 Besides rRNA and tRNA, some ribotoxins cleave mRNAs to inhibit translation in 
response to stress. E. coli TA system RelBE (B=antitoxin, E=toxin) has been implicated in 
inhibition of cell growth and dormancy (29). Under stress conditions, RelB is degraded and RelE 
activity is induced (30). RelE binds to ribosomes in the A site and cleaves the mRNA after the 
second base in the A site codon, thus arresting translation (31). Another TA system YoeB-YefM 
(YoeB=toxin, YefM=antitoxin) is widespread among archaea and eubacteria (32). Like RelE, 
YoeB also binds to the A site and cleaves mRNA. Both toxins require the ribosome for mRNA 
cleavage (33,34). Unlike RelE and YoeB, MazF works independently from ribosomes to cleave 
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mRNA in a sequence-specific manner (35). Additionally, MazF has been shown to cleave the 
anti-Shine-Dalgarno sequence of the 16S rRNA allowing for translation of leaderless mRNAs 
(36). This creates ribosome heterogeneity wherein a subset of ribosomes are selectively 
translating mRNAs that have been processed by MazF. Recent studies indicated that MazF may 
also target 23S rRNA and tRNAs indicating MazF may play other roles in translation regulation 
(37,38). These toxins are expressed in response to cellular stress to arrest cell growth and 
eventually will lead to programmed cell death. Another mechanism for programmed cell death is 
the anticodon nuclease, PrrC. E. coli strain prr expresses PrrC in response to infection by 
bacteriophage T4 (39). This is a “suicide” mechanism in which PrrC cleaves E. coli tRNALys 
resulting in inhibition of translation and eventually cell death.  
 Ribotoxins are also present in eukaryotes, most prominently in fungi. Fungal ribotoxins 
are produced by several species, many of which are entomopathogens or pathogenic to insects. 
They act as very potent inhibitors of protein translation by targeting ribosomes of a variety of 
organisms. Fungal ribotoxins act extracellularly likely as a defense mechanism. The biological 
function of fungal ribotoxins is unclear but studies have reported that the most-well studied are 
toxic against insects (40-43). Due to their potent toxicity, fungal ribotoxins have been 
extensively studied for potential biotechnical applications such as insecticides, anti-fungal 
agents, and even anti-tumor agents (44-46). The most well characterized fungal ribotoxin is α-
sarcin which cleaves the SRL loop in the 28S rRNA of the large ribosomal subunit, inactivating 
the ribosome (47).  
“Smart” ribotoxins 
 In addition to ribonuclease activity, studies have shown that some ribotoxins can remove 
one or more nucleotides from the damaged end(s) of the cleaved RNA. Ribotoxins which possess 
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this activity will be referred to as “smart” ribotoxins. The first smart ribotoxin was identified in 
2008 as RloC, a distant homologue of PrrC (48). RloC cleaves tRNAs in their anticodon loop 
similar to PrrC but with a preference for tRNAGlu and tRNAGln instead of tRNALys (49). After 
cleavage, the nucleotide at the wobble position is excised from the 5’-end of the 3’ fragment. 
RloC posseses an ABC ATPase domain with a distinct zinc-hook/coiled-coil insert which is 
similar to Rad50, an enzyme involved in the repair of double-stranded DNA breaks (50). It has 
been hypothesized that RloC acts as a sensor for double-stranded DNA breaks and responds by 
shutting down translation, thus providing the host a defense mechanism against infection (49). In 
2012, another smart ribotoxin, PaOrf2, may have nucleotide excision activity. PaOrf2, a subunit 
of Pichia acacia toxin, was reported to make one incision in the anticodon loop of tRNA 
followed by a second incision two nucleotides downstream, resulting in loss of a dinucleotide 
(51). However, a subsequent study did not observe the second incision and instead concluded 
that PaOrf2 makes a single incision at the wobble position (52). The removal of (a) nucleotide(s) 
particularly from the anticodon would result in a nonfunctional tRNA even once it was religated 
by an RNA repair system.  
1.2 RNA Repair 
RNA ligases 
 Many cellular processes such as splicing of introns from tRNA and mRNA require the 
incision of RNA molecules by nucleases followed by ligation or sealing of the RNA by an RNA 
ligase. RNA ligases can be categorized into two distinct groups which differ greatly in their 
structures, active sites, and mechanisms. In addition to their role in normal cellular processes, 
recent studies have shown that some organisms use RNA ligases as the main component of RNA 
repair systems which act to reverse specific RNA damage by ribotoxins. Below is a summary of 
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what is known about the two types of RNA ligases, their normal cellular functions, and their 
roles in RNA repair.  
5’-P Ligases or ATP-grasp ligases 
 In yeast, tRNA splicing occurs in three steps (Figure 1.4, top pathway) (53). First, the 
pre-tRNA is cleaved on either side of the intron resulting in a 5’-fragment ending in 2’, 3’-cyclic 
phosphate and a 3’-fragment with 5’-OH (54). Next, the two termini are processed by kinase 
activity which opens the 2’, 3’-cyclic phosphate to yield 3’-OH and phosphatase activity which 
adds a phosphate group to the 5’-OH. In the final step, 3’-OH and 5’-P are ligated together by the 
formation of a phosphodiester bond creating a mature tRNA (55,56). Interestingly, all three of 
the activities in the last two steps are performed by the same enzyme. Yeast Trl1 consists of three 
domains: an N-terminal ligase domain, a central polynucleotide kinase domain, and a C-terminal 
phosphodiesterase domain. In plants, tRNA splicing occurs similarly with a homolog of Trl1 
(57). Ligases such as Trl1 which are capable of ligating 3’-OH and 5’-P termini are referred to as 
5’-P RNA ligases. These enzymes are sometimes called ATP-grasp or ATP-dependent ligases as 
they use ATP as a cosubstrate during ligation, releasing pyrophosphate and forming a covalent 
lysl-N-AMP intermediate. AMP is then transferred to the 5’-P and the 3’-OH attacks the 5’-P, 
sealing the RNA (58).   
3’-P Ligases or RtcB 
 For many years, it was known that tRNA splicing in vertebrates and archaea occurred via 
a very different mechanism than in plants and fungi. Studies had shown that during 5’-P ligation 
in yeast, exogenous labelled phosphate from ATP was incorporated into the splice junction by 
Trl1. But during tRNA splicing in vertebrates, exogenous phosphate was not incorporated 
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indicating that splicing occurred by an unknown mechanism (59-61). Ligase activity which was 
capable of directly sealing 2’, 3’-cyclic P and 5’-OH was observed in HeLa cell extracts, 
Desulfurococcus mobilus, and Haloferax volcanii but attempts to isolate and identify the enzyme 
responsible were unsuccessful (62-64). 
 More than twenty years later, three studies using different organisms were simultaneously 
released which assigned this 3’-P ligase activity to an enzyme family called RtcB. RtcB purified 
from E. coli was shown to ligate broken tRNA-like structures with 2’, 3’-cyclic phosphate and 
5’-OH (65). 3’-P ligase activity was isolated from the archaeal organism Methanopyrus 
kankdleri and was characterized as RtcB; furthermore, recombinant Pyrobaculum aerophilum 
RtcB was shown to ligate spliced tRNAs (66). Finally, the 3’-P ligase previously purified from 
HeLa cell extract was identified as HSPC117 of the RtcB family (67).  
 One of the reasons RtcB was difficult to identify is that it shares no sequence or structural 
homology to previously characterized RNA ligases. In contrast to 5’-P ligases which are ATP 
and Mg+2-dependent, RtcB is stimulated by GTP and is most active with Mn+2 (68). RtcB 
directly seals 3’-P and 5’-OH termini via a three-step mechanism (69). First, an active site 
histidine residue (His337 in E. coli RtcB) reacts with GMP to form a covalent histidinyl-N-GMP 
intermediate. GMP is then transferred to the 3’-P, producing a polynucleotide-(3’)pp(5’)G 
intermediate. Finally, 5’-OH attacks the -N(3’)pp(5’)G to seal the phosphodiester bond. Despite 
the differences in mechanism and active sites between 5’-P and 3’-P ligases, both enzymes 
utilize two divalent metal ions for catalysis (70). M1 is involved in stabilizing the pentavalent 
transition state by neutralizing the negative charge on the α-P. M2 orients and stabilizes the 
pyrophosphate leaving group.  
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 Not long after the identification of its role in tRNA splicing, RtcB was also reported to be 
involved in the unfolded protein response (UPR) in animals (71). When unfolded proteins 
accumulate in the endoplasmic reticulum, an endonuclease called IRE1 excises an intron from 
the XBP1 mRNA transcript (72). Previous studies showed that XBP1 was religated by an 
unknown RNA ligase, forming an active XBP1 transcription factor which went on to induce the 
UPR pathway. In 2014, RtcB was identified as this unknown RNA ligase in Caenorhabditis 
elegans (73). The same study reported that RtcB is necessary for XPB1 ligation in C. elegans 
indicating that this organism does not contain another ligase capable of this function.  
RNA Repair systems  
 Bacteria and bacteriophage have a very long-standing conflict resulting in the 
development of countless defensive and offensive tools against one another in the struggle to 
survive.  Therefore, it is not surprising that the first RNA repair system was identified in T4 
bacteriophage and that is was shown to counteract the host’s self-restriction mechanism, PrrC.  
When T4 infects the bacterial cell, PrrC is activated to cleave the host’s tRNALys to inhibit 
translation and contain the infection. However, T4 phage encodes an RNA repair system 
consisting of two proteins- 3’-phosphatase-polynucleotide kinase (Pnkp) and RNA ligase (Rli) 
which restores tRNALys and allows the virus to evade restriction (Figure 1.6) (74). Together Pnkp 
and Rli work similarly to Trl1 with Pnkp containing the phosphatase and kinase activities and 
Rli, the ligase activity (39). Pnkp heals the 2’,3’-cyclic phosphate and 5’-OH to 3’-OH and 5’-P 
then Rli joins the two ends together.  
 The identification of a viral RNA repair system led researchers to look for RNA repair 
systems in other organisms. In 2005, Pnkp from the bacterial organism Clostridium 
thermocellum was shown to be capable of kinase, phosphatase and adenylyltransferase activities, 
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yet was unable to repair RNA in vitro (75).  In 2009, our lab was able to show that PnkP from 
Anabaena variabilis was able to carry out repair of tRNAs in vitro but only in the presence of 
another protein called Hen1 (76). Like T4 PnkP, A. Variabilis Pnkp processes 2’,3’-cyclic 
phosphate and 5’-OH into 3’-OH and 5’-P. However, prior to ligation, Hen1 carries out 2’-O-
methylation at the 3’ cleavage site. Due to the 2’-methylation, the repaired RNA is no longer 
vulnerable to cleavage at that site. The in vivo substrate for bacterial Pnkp/Hen1 RNA repair 
systems has yet to be identified as this system can repair a variety of substrates in vitro (77).  
 Approximately 250 bacterial species are predicted to contain Pnkp/Hen1-like RNA repair 
systems. A BlastP search for A. Variabilis Hen1 revealed 10 additional species which contain 
Hen1 and two additional genes which were likely involved in RNA repair but not in the same 
operon as Hen1 (78). One gene encodes a protein which is similar to the ligase domain of 
bacterial Pnkp and the other encodes a protein which is similar to T4 Pnkp. It was hypothesized 
that these three proteins which contain kinase, phosphatase, ligase, and methyltransferase 
activities could comprise an RNA repair system equivalent to that of A. Variabilis. Indeed, 
recombinant Capnocytophaga gingivalis Pnkp1-Rnl-Hen1 was able to repair ribotoxin-treated 
RNAs. The in vivo substrate for Pnkp1-Rnl-Hen1 also remains elusive.  
 All three RNA repair systems discussed so far utilize 5’-P ligase activity. Many bacteria, 
including E. coli, do not have Pnkp/Hen1. However, despite their tRNAs not containing introns, 
many bacteria do contain RtcB. This led researchers to consider possible roles for RtcB in 
bacteria including RNA repair. In one of the three studies first naming RtcB as the 3’-P ligase, 
Shuman and coworkers demonstrated that E. coli RtcB sealed broken tRNA-like structures (65). 
E. coli RtcB is encoded by the rtcAB operon which is regulated by transcription factor RtcR. 
RtcR is transcribed by alternative sigma factor, α54, under stress conditions. RtcA was previously 
10 
 
reported to perform a cyclization reaction to convert 3’-P to 2’,3’-cyclic phosphate (79). The role 
of RtcA in the RtcB repair system is unclear as RtcB can use 3’-P termini as substrates for 
ligation. The cellular function of the RtcAB repair system itself is still under investigation. 
Studies have reported that rtcAB is expression is activated by damage to the translation 
machinery and oxidative stress (80). Recently, RtcB has been shown to reverse ribosome 
heterogeneity caused by MazF by repairing the 16S rRNA (81). A comparison of the domains of 
5’-P ligases and 3’-P ligases are shown in Figure 1.7. 
 Current knowledge of RNA damage and repair is shown in Figure 1.8. RNA damage 
typically results in termini with 2’,3’-cyclic phosphate and 5’-OH termini (center). The termini 
can be directly sealed by 3’-P ligase RtcB (left) resulting in an RNA that is “as good as new”. 
The termini can also be processed by phosphatase and kinase activity resulting in 3‘-OH and 5’-
P. At this point, two ends can be ligated also resulting in an “as good as new” RNA (right, top). 
However, after end processing, the 2’-OH group can be methylated so that the resulting ligation 
product is “better than new” (right, bottom) as the molecule is no longer susceptible to damage at 
that site.   
Other proteins found in RNA Repair Operons 
 RNA repair systems generally consist of an RNA ligase component and, if the ends of the 
damaged RNA are not compatible with the ligase, RNA end-processing enzymes such as 
phosphates and kinases. However, in 2016, extensive bioinformatic analyses of RNA repair 
operons performed by Aravind et al. revealed that, in addition to RNA ligases and end-
processing enzymes, RNA repair systems typically contain a number of other scaffold and/or 
cofactor proteins (82). One example of a protein that was found to often associate with 5’-P and 
3’-P RNA ligases was a Hen1 methylase which the authors hypothesized could be involved in 
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protection of the damaged RNA ends from degradation. Another interesting discovery was a 
nucleotidyltransferase which was found to be associated with a subset of diverse RNA ligases. 
This protein was named RNA ligase-associating Polβ (RlaP).  
1.3 Polβ Nucleotidyltransferase Superfamily 
General Overview of NTases  
 Nucleotidyltransferases are enzymes which transfer nucleoside monophosphate (NMP) 
moieties from NTP onto a hydroxyl group of an acceptor molecule which can be protein, DNA, 
RNA, or small molecule. NTases are divided into more than ten distinct superfamilies (83). Each 
NTase superfamily is conserved at the amino acid sequence level but there is little sequence or 
structural similarity between the superfamilies. Of these superfamilies, the Polβ NTase 
superfamily is of interest as its one of the most widespread and is highly diverse. This 
superfamily is named for one of its members, DNA polymerase β, which performs base excision 
repair in eukaryotes (84). Polβ NTases have been shown to carry out a variety of important 
biological functions such tRNA maturation (85), mRNA processing (86), DNA repair (84), cell 
signaling (87), and innate immune response (88). Despite the characterization of many Polβ 
NTases, there are still large families of Polβ NTases whose cellular functions remain unknown 
(89).  
 Due to the diversity of functions performed by Polβ NTases, protein structures within this 
superfamily are highly diverse as well. However, members of this superfamily share a common 
NTase-fold which carries out the NMP transferase activity (89). Figure 1.9 shows the NTase fold 
structure of DNA polymerase X from African swine fever virus. The minimal NTase fold 
consists of three beta sheets (shown in yellow) flanked by four alpha helices (shown in blue). 
12 
 
Three highly conserved negatively charged residues, usually aspartic acid, but sometimes 
glutamic acid, are responsible for coordinating two divalent metal ions and activating the 
acceptor hydroxyl group on the substrate. Most Polβ NTases act via the same two-metal-ion 
catalysis as replicative DNA polymerases which is shown in Figure 1.10 (90). Metal ion A 
lowers affinity of the 3’-OH for its hydrogen, leaving 3’-O- to conduct a nucleophilic attack on 
the α-phosphate of the NTP. Metal ion B helps to stabilize the pyrophosphate leaving group. 
Both metal ions assist in stabilizing the pentacovalent transition state. In addition to the catalytic 
aspartic acid residues, NTase folds contain a highly conserved GS or GG motif which harbors 
the substrate in the active site. In addition to the NTase fold, Polβ NTases contain a variety of 
other active and structural domains which allow them to carry out a wide array of biological 
functions on a variety of substrates (83).  
 Because of the large and diverse nature of the NTase superfamily, classifying known 
members and identifying new ones has proved challenging. In 2009, Ginalski and coworkers 
performed a comprehensive in silico analysis of all NTase fold proteins, providing insight into 
their evolutionary, structural, and functional relationship to one another (89). This work divided 
the NTase superfamily up into 26 groups, 10 of which were newly identified (Figure 1.11, right). 
From PSI-BLAST and RPS-BLAST data, groups of closely related proteins were linked to form 
a connectivity network of the entire NTase superfamily (Figure 1.11, left). Due to the important 
biological roles of known NTases, the identification and characterization of these unknown 
NTase families have the potential to lead to innovative and exciting new discoveries.  
Pol-β and other NTases that act as polymerases 
 Many NTases function as non-replicative DNA or RNA polymerases and perform 
essential biological functions. For example, the DNA polymerase X family which includes DNA 
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polymerases β, λ, and µ, and terminal transferase (Tdt) is involved in DNA repair. Polβ works in 
a template-dependent manner to replace a damaged nucleotide during base excision repair (84). 
Polymerases λ and µ are both involved in non-homologous end joining to repair breaks in 
double-stranded DNA (91). Tdt synthesizes the N region of immunoglobulin genes during 
antibody gene recombination, allowing for junctional diversity. DNA polymerase X family 
catalyzes the addition of dNMP from dNTP and contains the highly conserved NTase fold.  
 Some RNA polymerases are also members of the Polβ superfamily. Transfer RNA 
nucleotidyltransferases (CCA-adding enzymes) are a group of enzymes which catalyze the post-
transcriptional addition of three nucleotides, CCA, onto the 3’ end of an immature tRNA, 
allowing the tRNA to be charged efficiently and correctly by its cognate tRNA synthetase (92). 
CCA-adding enzymes are particularly interesting because they utilize the same active site to 
catalyze the template-independent sequential addition of two CTP followed by a single ATP with 
high fidelity. The crystal structure of Archaeoglobus fulgidus CCA-adding enzyme showed that 
this is accomplished in two ways (85). First, an arginine residue and the tRNA backbone allow 
for hydrogen interactions with CTP or ATP but not with GTP or UTP. Second, the size of the 
nucleotide binding pocket changes as the tRNA lengthens at first allowing only for 
accommodation of the pyrimidine base then expanding after the addition of C75 to allow ATP 
entry.  
 Other NTases are known to perform necessary biological functions by polymerizing 
RNA. For example, adenylation or the non-templated addition of nucleotides to an RNA is 
frequently used to regulate RNA stability and activity. In eukaryotes canonical poly(A) 
polymerases (PAPs) catalyze addition of a poly(A) tail to the 3’ end of mRNAs which is required 
for mRNA stabilization, export, and efficient translation. However, both eukaryotes and bacteria 
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contain noncanonical PAPs (nc-PAPs) which catalyze addition of NMP onto the 3’ end of an 
RNA for the purpose of a variety of other cellular functions including RNA degradation (93) 
(94). In 2016, a family of human NTases, FAM46, (Figure 1.11, Group 25) were shown to be nc-
PAPs (95). The exact role of this family remains unknown though the proteins have been linked 
to the growth factor-β signaling pathway and cell differentiation. Mutations in FAM46 proteins 
have been associated with many diseases including retinal disease (95), metastatic melanoma 
(United States Patent US 7615349 B2), multiple myeloma (96), and lung tumors (97).  
 In addition to adenylation, nc-PAPs have also been shown to use uridylation to regulate 
the stability and processing of RNAs though to a lesser extent. Nucleotide specificity in nc-PAPs 
ranges from strictly ATP to equal ATP and UTP to strictly UTP. Human terminal 
uridylyltransferases (TUTases) are nc-PAPs which play fundamental roles in the degradation of 
mRNAs and regulation of miRNAs. Human TUT4 and TUT7 have both been demonstrated to 
poly(U) uridylate mRNAs with short poly(A) tails, targeting them for global decay (98). 
Additionally, TUT4 and TUT7 have been implicated in the mono-uridylation of miRNAs 
involved in cell differentiation and Hox gene control (99). These are some of the important roles 
that polymerase-like NTases play within the cell.  
NTases that generate dinucleotides 
 Not all NTases have polymerase-like functions. Many NTases utilize small molecules 
such as another nucleotide to generate linear or cyclic dinucleotides. In higher organisms, these 
dinucleotide products act as secondary messengers in cell signaling pathways. Adenylate 
cyclases convert AMP to 3’, 5’-cyclic AMP (cAMP). cAMP is a very important secondary 
messenger molecule involved in a variety of signal transduction pathways within the cell such as 
metabolism of glucose and lipids and regulation of cardiac myocyte contraction (100) (101). 
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Other NTases such as cyclic GMP-AMP synthase (cGAS) and 2’, 5’-oligoadenylate synthase 
(OAS) are involved in innate immune response in vertebrates. cGAS senses cytosolic DNA 
arising from a viral or bacterial infection and responds by producing cyclic GMP-AMP 
(cGAMP). cGAMP activates the stimulator of interferon genes (STING) pathway which results 
in production of interferons and cytokines (88). OAS proteins are also activated by the presence 
of dsDNA in the cytoplasm; however, OAS produces 2’, 5’-oligoadenylates (oligoA) which 
activate RNaseL to degrade the invading DNA (102).  
 Cyclic dinucleotides produced by NTases have also been found in bacteria though they 
have different chemical structures than those in vertebrates. In 2012, di-nucleotide cyclase 
(DncV) was shown to produce cGAMP and to increase virulence in Vibrio cholerae (103). 
However, DncV produces 3’, 5’-cGAMP rather than 2’, 5’ linkages like cGAS. In 2019, it was 
discovered that CdnE generates 3’, 5’-cUAMP which is the first known pyrimidine-containing 
cyclic dinucleotide (104). This study also showed that a related NTase, CdnD02 produces a 
cyclic trinucleotide cyclic-AMP-AMP-GMP also the first of its kind. The signaling pathway that 
these bacterial secondary messengers are involved in are still under investigation.   
RlaP-NTase 
 As mentioned above, RlaP-NTase has been found in a set of diverse RNA repair operons 
yet its biological function is unknown. RlaP-NTase is associated with both 5’-P ligases (Figure 
1.12) and 3’-P ligases (Figure 1.13). For 5’-P ligase operons, RlaP-NTase is frequently found in 
between Hen1 and an Rnl4 ligase component. Other components in the operons include P-loop 
kinase, Thg1, and Rot/TROVE+vWA. RlaP-NTase is also associated with Rnl1 and Rnl2 ligases 
though less frequently. Operons containing 3’-P ligases and RlaP-NTase also contain RtcR, 
RtcA, and Rot/TROVE+vWA (82). RlaP is a Polβ NTase which has a C-terminal alpha-helical 
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extension in addition to its NTase fold domain. According to the classification of NTases by 
Ginalski and coworkers, RlaP-NTase is in Group 14 which contains “predicted 
nucleotidyltransferases” (Figure 1.11) (89). Because of its association with diverse RNA ligases 
which act on different substrates, Aravind hypothesized that the function of RlaP-NTase is likely 
related to RNA ligase activity.   
1.4 Figures 
 
Figure 1.1. The mechanism by which RNA is cleaved (1). A base, such as a water molecule or a 
metal ion acting as a Brönsted base, abstracts a proton from the 2’-OH on the ribose. 2’-O- then 
conducts a nucleophilic attack on the neighboring 3’-phosphate. The 5’-OH group leaves, 
resulting in cleavage of the phosphodiester bond. The 5’-fragment now ends in 2’, 3’-cyclic 
phosphate and the 3’-fragment begins with 5’-OH. This reaction can occur either spontaneously 





Figure 1.2. A summary of known ribotoxin targets. The incision sites are marked with orange 
arrows. A large number of ribotoxins, including Colicin E5, PrrC, VapC, and Colicin D, cleave 
tRNA in the anticodon loop (A). Other ribotoxins target rRNA in the 50S ribosomal subunit 
(VapC20, Sarcin, Ricin), rRNA in the 30S ribosomal subunit (Colicin E3), or translating mRNA 





Figure 1.3. Structures of tRNAs cleaved by two colicins in vitro (2). Colicin E5 cleaves tRNAs 
which have queuine (Q) at position 34 (upper panel). Colicin D cleaves four isoaccepting 
tRNAArg (lower panel). The incision sites are marked with shaded triangles. The open triangles 





Figure 1.4. Two distinct tRNA splicing pathways (53). Both pathways begin with excision of the 
intron by an endonuclease. In yeast and plants, ligation occurs via 5’-P pathway by an enzyme 
called Trl1 in yeast (upper pathway). Trl1 generates 3’-OH and 5’-P termini using its 
phosphatase (CPD) and kinase domains. These ends can then be sealed by Trl1’s ligase domain. 
In vertebrates and archaea, 3’-P ligation pathway is used (lower pathway). RtcB directly seals the 












Figure 1.6. T4 RNA repair system (74). Host restriction mechanism activates PrrC using Stp. 
PrrC cleaves tRNALys in its anticodon loop. T4 proteins Pnk and Rli repair the tRNAs, allowing 





Figure 1.7. RNA ligase operons. A) T4 Pnkp contains kinase and phosphatase domains while 
ligase activity comes from Rnl. B) A. Variabilis Pnkp contains all three domains necessary for 
ligation- kinase, phosphatase, and ligase. Hen1 is required for Pnkp activation and has 
methyltransferase activity. C) Homo sapiens RtcB contains one domain with all activities 




Figure 1.8. RNA damage and repair. RNA damage is damaged by a ribotoxin (center). 3-P 
ligase RtcB can directly seal the RNA, producing “as good as new” (left). 5’-P ligase must first 
heal the ends using phosphatase and kinase activity. At this point, direct sealing results in an “as 
good as new” RNA (right, top). However, after end processing, the 2’-OH group can be 






Figure 1.9. Structure of NTase fold from African swine fever virus DNA polymerase X (89). 
Three β-sheets (yellow) are flanked by four α-helices (blue). The three catalytic aspartic acid 







Figure 1.10. The mechanism used for NMP transfer by NTases (90). Aspartic acid residues 
coordinate two divalent metal ions. Metal ion A lowers affinity of the 3’-OH for its hydrogen, 
leaving 3’-O- to conduct a nucleophilic attack on the α-phosphate of the NTP. Metal ion B helps 
to stabilize the pyrophosphate leaving group. Both metal ions assist in stabilizing the 




Figure 1.11. Classification and Connectivity network of NTase superfamily (89). NTases that 
are closely related by both PSI-BLAST and RPS-BLAST are surrounded by black circles 
(known NTases) or red circles (newly identified NTases) (left). The distribution between 
eukaryotic, archaeal, bacterial, and viral sequences of each closely related is shown (right) along 






Figure 1.12. Contextual network and RNA repair operons of 5’-P or ATP-grasp ligases (82). 
Contextual network shows protein domains and how they are connected to 5’-P ligases and to 
one another (A). (B-Q) Gene neighborhoods identified as potential 5’-P ligase RNA repair 




Figure 1.13. Contextual network and RNA repair operons of 3’-P ligases or RtcB (82). 
Contextual network of 3’-P ligases and their connected proteins (A). (D-R) Gene neighborhoods 






CHAPTER 2: IN VITRO RECONSTITUTION OF A NOVEL FAMILY OF 
NUCLEOTIDYLTRANSFERASES POTENTIALLY INVOLVED IN RNA REPAIR 
2.1 Introduction 
 The Pol NTase superfamily is comprised of large and highly diverse families of 
proteins. Essentially, all known enzymatically active members of this superfamily transfer NMP 
or dNMP from NTP or dNTP to an acceptor hydroxyl group of a macromolecule or a small 
molecule. The members of the superfamily share the NTase structural motif that possesses 
several conserved residues. In particular, three conserved aspartate/glutamate residues coordinate 
two divalent ions for NTP or dNTP binding as well as activation of the acceptor hydroxyl group 
of the substrate for catalysis. Biologically, NTases play many important cellular functions, such 
as RNA polyadenylation by Poly(A) polymerases (86,105), tRNA maturation by CCA-adding 
enzymes (85,106), DNA repair by Pol NTase (), cell signaling by adenylate cyclase (87), 
and innate immune signaling by cyclic GMP-AMP synthase (cGAS) (88). Very recently, 
bacterial cGAS-like NTases have been shown to synthesize new signaling molecules that have 
not been observed before (104). 
Approximately twenty years ago, Aravind and Koonin performed the first major 
bioinformatic analysis of Pol NTase superfamily (83), resulting in identification of three new 
NTase families. Ten years later, Kuchta et al. carried out a comprehensive classification of 
proteins possessing an NTase fold, with emphasis on identifying new human NTase families 
(89). One of the newly identified human NTases was later shown to be cGAS that produces 
cyclic GMP-AMP (cGAMP), an important signaling molecule in human innate immunity. 
Recently, during comprehensive bioinformatic analysis of proteins involved in RNA repair, 
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Burroughs and Aravind have identified that genes encoding some NTases of the PF10127 family 
are in the same operon as the genes encoding a variety of RNA ligases (82). These NTases were 
therefore named RlaP (RNA ligase-associating Pol) NTases and have been predicted to be 
involved in RNA repair. To date, there has been no report of enzymatic activities or biological 
roles of NTases of the PF10127 family, which currently consists of more than 6,000 protein 
sequences. 
Protein translation is essential for all organisms and is highly conserved. It is therefore a 
major target of biological toxins. Among cell-killing toxins targeting protein translation, 
ribotoxins that damage essential RNAs required for protein translation represent the largest 
group. To counter cell-killing by ribotoxins, some organisms and viruses employ RNA repair. 
This is exemplified by the action of the first RNA repair system from bacteriophage T4 
discovered thirty years ago (39). We have also in vitro reconstituted the activity of Pnkp/Hen1 
RNA repair system, which is widely distributed in bacteria (76). RtcB, a new class of RNA 
ligase, was discovered as the RNA ligase component for tRNA splicing in archaeal and 
eukaryotic organisms (66,67). The majority of RtcB, however, are found in bacteria. Because 
tRNAs in bacteria have no introns, it is reasonable to assume that most bacterial RtcB are likely 
to be involved in RNA repair (65). 
Most cell-killing ribotoxins, such as PrrC (39), sarcin (47), -toxin (108), colicin E3 (3), 
colicin E5 (16), and colicin D (3), make a single cut of an essential RNA involved in protein 
translation to inhibit protein synthesis in vivo. To counter RNA damage by such “ordinary” 
ribotoxins, one would expect that direct RNA repair would be sufficient to restore the biological 
functions of the damaged RNA. Indeed, the T4 RNA repair system was able to restore E. coli 
tRNALys cleaved by ribotoxin PrrC, preventing the T4-infected E. coli cells from committing 
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suicide (39). In addition to these ordinary ribotoxins, however, “smart” ribotoxins have been 
identified. A “smart” ribotoxin is defined here as a ribotoxin that not only makes a cut on its 
RNA substrate, but also carries out additional enzymatic activities that result in loss of 
nucleotide(s) in the cleaved RNA. Two known “smart” ribotoxins are RloC and PaOrf2 (50,51). 
RloC first makes a cut on tRNA similar to ribotoxin PrrC, then excises the 3’-terminal nucleotide 
of the 5’-half of the cleaved tRNA. PaOrf2 cleaves tRNA like -toxin, followed by a second cut 
to remove two 3’-terminal nucleotides of the 5’-half of the cleaved tRNA. Therefore, due to the 
loss of nucleotide(s) on the damaged RNA by “smart” ribotoxins, it is uncertain whether such 
damaged RNAs can be repaired and still maintain their biological activities. 
To provide insight into the enzymatic activity and biological function of RlaP-NTase, we 
cloned, overexpressed, and purified two RlaP from Pseudomonas organisms and performed in 
vitro reconstitution and structural studies. Our studies revealed that RlaP-NTase transfers one or 
two NMP to the 3’-hydroxyl group of RNA, and the enzyme possesses a certain degree of 
substrate specificity that is consistent with its involvement in RNA repair. In addition, we 
performed aminoacylation assays of the repaired tRNA to assess the requirement of RlaP-NTase 
for RNA repair. The collective studies described here led us to propose that RlaP-NTase is the 
antidote of “smart” ribotoxins. 
2.2 Materials and Methods 
Expression and Purification of RlaP-NTase 
 The RlaP-NTase gene from pseudomonas fluorescens and pseudomonas aeruginosa were 
purchased from IDT as gBlock Gene Fragments (Table 2.1 and Table 2.2). The DNA fragments 
were digested by restriction enzymes and then inserted into pETDuet-1 with a His6-tag using T4 
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DNA Ligase (New England Biolabs). The primers from Table 2.3 were used to amplify the 
gBlock fragments to make the Non-His constructs in the same manner as the His-tagged 
plasmids. The resulting plasmids were used to overexpress PfRlaP-NTase or PaRlaP-NTase in E. 
coli strain BL-21 (DE3) by the addition of 0.5 mM IPTG. RlaP-NTase was expressed for 16 
hours at 18 oC. Cells were harvested by centrifugation. PfRlaP-NTase pellets were resuspended 
in 20 mM Tris-HCl pH 8.0, 10 mM NaCl, 2% glycerol and 1 mM DTT and then lysed by three 
passes through a French press at 1500 psi. PfRlaP-NTase was purified using DEAE ion 
exchange, Heparin affinity, and Mono Q ion exchange chromatography. PaRlaP-NTase pellets 
were resuspended in 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 2% glycerol and 1 mM DTT, lysed 
by French press, and purified using Heparin affinity and Mono Q ion exchange chromatography. 
Both proteins were stored at -80 oC in Storage buffer (10 mM HEPES pH 7.0, 400 mM NaCl and 
2% glycerol). An additional size-exclusion chromatography step was carried out for PfRlaP-
NTase used for crystallization. 
Identification of in vivo Substrate 
 Total RNA was purified from E. coli DH5α cells using TRIzol reagent (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. Total RNA was precipitated in 75% cold 
ethanol, pelleted by centrifugation, and resuspended in 1X Reconstitution buffer (50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 5 mM MnCl2). Genomic DNA was isolated from E. coli DH5α cells 
using DNeasy Blood and Tissue kit (Qiagen) according to the manufacturer’s protocol. Genomic 
DNA was eluted from the column using 1X Reconstitution buffer. Purified genomic DNA was 
incubated with RNase I (Thermo Fisher Scientific) for 30 minutes at 37 oC according to the 
manufacturer’s instructions. To isolate E. coli protein, 300 mL DH5α cells (OD=0.4) were 
pelleted and resuspended in 5 mL of 1X Reconstitution buffer. Additionally, RNase I and DNase 
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I (Sigma Aldrich) and 5 mM MgCl2 were added. The sample was incubated on ice for 30 
minutes to allow RNA and DNA to be degraded. The cells were lysed by three passes through a 
French press at 1500 psi. The lysate was centrifuged for 45 min at 15,000 rpm to isolate the 
soluble protein fraction. The resulting supernatant was concentrated in a 3K Amicon Ultra 
centricon (Millipore) to remove digested nucleotides and small molecules. 
Reactions were set up in Reconstitution buffer containing either 1 µg total RNA, 0.5 µg 
genomic DNA or 1 µg total protein, 10 µM NTP spiked with 125 nM [α-32P]-NTP and either 5 
µM PfRlaP-NTase, PaRlaP-NTase or Storage buffer. Reactions were incubated at 25 oC for 30 
minutes. The reactions were stopped by addition of 2X DPAGE loading dye and heating at 95 oC 
for 3 min. RNA and DNA reactions were run on 10% DPAGE gels and protein reactions were 
run on 12% SDS gel. Gels were dried and exposed together to a phosphorimaging plate and 
radioactivity was detected using a PhosphorImager system. 
In vitro Reconstitution of RlaP-NTase Activity Using Synthetic RNA 
 For in vitro RlaP-NTase reactions, RNA oligomers first were annealed by heating for 3 
min at 95 oC then cooled quickly for 10 min on an ice bath. Unless stated otherwise, RlaP-NTase 
reactions were carried out with 5 µM annealed RNA substrate, 2.5 µM PfRlaP-NTase or 
PaRlaP-NTase, and 5 µM NTP spiked with 62.5 nM [α-32P]-NTP in Reconstitution buffer. 
Reactions were carried out for 30 min at 25 oC. DPAGE loading buffer was added and 2 µL of 
each 10 µL reaction was run on a 15% DPAGE gel. The gel was dried and exposed to a 
phosphorimaging plate and radioactivity was detected using a PhosphorImager system. 
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Reactions with DNA and dATP were carried out in the same way as RNA and NTP 
reactions. The reactions for metal dependency were carried out as described above with the 
exception that 5 mM MnCl2 was replaced by the metal indicated in Figure 5A. 
Preparation of Repaired tRNAs for Aminoacylation 
 Asp-P42 RNA was annealed to either Asp-34 RNA or Asp-33 RNA as described 
previously. Reactions in preparative scale (300 µL total volume) were carried out in 
Reconstitution buffer containing 20 µM Asp-34/P42 or Asp-33/P42, 10 µM PfRlaP-NTase, and 
400 units of RNase inhibitor. Each of the RNA mixture was reacted at three different conditions: 
no NTP, at the presence of 100 µM GTP, or at the presence of NTP mixture (25 µM each of 
ATP, GTP, UTP and CTP). After 1 hour of incubation at 25 oC, 20 µM ATP and 350 units of T4 
RNA ligase 1 were added directly to the reaction solution to ligate two RNA fragments into the 
full-length tRNA. The ligation reaction was carried out for 1 hour at 25 oC, and the ligated tRNA 
product was purified by 15% DPAGE. 
Aminoacylation Assays 
 Prior to aminoacylation reaction, each tRNA was folded by incubating at 75 °C for 3 min, 
followed by addition of 2 mM MgCl2, once the solution was cooled to 65 °C. The folding sample 
was finally cooled to the room temperature. Aspartylation of the repaired tRNAs (10 µM) by 
AspRS was carried out in 40 mM HEPES, pH 7.5, 4 mM ATP, 8 mM MgCl2, 200 µM unlabeled 
aspartic acid, 50 µCi 
3
H-[2,3]-L-aspartic acid, and 1 µM of AspRS. After 15 min of reaction at 
37 °C, tRNAs were recovered via TCA precipitation on filter papers pre-soaked with 10% TCA. 
The filter papers were washed 3 times with 10% TCA to remove unreacted aspartic acid, 
followed by one time wash with 100% ethanol. After air dry, the filter papers were subject to 
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scintillation counting. The same experiment using the in vitro transcribed tRNAHis as the 
background control. All assays were repeated three times and the data from the sets of 
experiments were used for the preparation of Figure 7. 
2.3 Results and Discussion 
Bioinformatic Analysis 
 To provide insight into distribution of RlaP-NTase in a broader context of the PF10127 
family, we performed bioinformatic analysis of protein sequences of the PF10127 family via 
construction of its Sequence Similarity Network (SSN) (Figure 2.1 Figure 2.2) (109,110). SSN 
of the PF10127 family revealed that the overwhelming majority of NTases are from bacteria 
(Figure 2.1A, colored blue). However, a small number of NTases are also found in eukaryotic 
and archaeal organisms (Figure 2.1A, colored red and green). Interestingly, a significant number 
of NTases are from viruses (Figure 2.1A, colored cyan), including bacteriophage T4 where the 
first RNA repair system was discovered (39). At Ecutoff value of 1e-30, the nodes of NTases are 
distributed into eight major clusters, several minor clusters, and approximately forty isolated 
ones (Figure 2.1A). The majority of NTases are present in cluster 1, which can further be divided 
into sub-clusters 1a, 1b, and 1c (Figure 2.1A). Both RlaP-NTases under current study belong to 
cluster 1a (Figure 2.1A, marked with orange arrows), and the NTase from bacteriophage T4 
(T4NrdC.11) is present in cluster 5 (Figure 2.1A, marked with a magenta arrow). 
As shown in Figure 2.1B, the genes encoding PfRlaP-NTase and PaRlaP-NTase are in the 
same operons as the gene encoding RtcB, an RNA ligase (65). Both operons are regulated by 
RtcR (111), which is positioned upstream of the operons and is transcribed in the opposite 
direction (Figure 2.1B, colored green). PfRlaP-NTase and PaRlaP-NTase share 62% sequence 
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identities (Figure 2.3). The recombinant PfRlaP-NTase and PaRlaP-NTase were overexpressed 
in E. coli and purified to homogeneity via several steps of chromatography (Figure 2.4). 
Identification of in vivo RlaP-NTase Substrates 
 To shed light on potential in vivo RlaP-NTase substrates, we isolated total RNAs, DNA, 
and proteins from E. coli cells and carried out reactions with 32P--NTPs without and with the 
presence of PfRlaP-NTase and PaRlaP-NTase (Figure 2.5, Figure 2.6n and Figure 2.7). In order 
to compare the results of different reactions quantitatively, the reactions using total E. coli 
RNAs, DNA, and proteins as substrates were carried out under identical conditions. Furthermore, 
three gels analyzing these reactions were exposed to a single imaging plate together, and the 
entire imaging plate was processed to ensure that the images from three gels were at the same 
level of brightness and contrast. 
As shown in Figure 2.5, several E. coli RNAs matching the sizes of ribosomal RNAs, full-
length tRNAs, and cleaved tRNAs were radiolabeled only in the presence of RlaP-NTase (lanes 
2, 4, 6, and 8), indicating that RNAs are the substrates of RlaP-NTase. Since all four NTPs are 
able to react with RNAs, we conclude that RlaP-NTase exhibits little substrate specificity for 
NTPs. We carried out the same reactions with E. coli genomic DNA and did not observe 
significant reaction (Figure 2.6), indicating that E. coli genomic DNA is unlikely a substrate of 
RlaP-NTase in vivo. Finally, we also carried out the reactions with E. coli proteins and concluded 
that E. coli proteins are not substrates of RlaP-NTase (Figure 2.7). 
In vitro Reconstitution of RlaP Activity Using Synthetic RNAs 
 To provide chemical and mechanistic insight into the reactions catalyzed by RlaP-NTase, 
we employed two synthetic RNAs, which mimic the product of tRNAAsp cleavage by colicin E5 
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when annealed together, as potential substrates (Figure 2.8A). In addition, each RNA has three 
variants depending on whether the terminal hydroxyl groups at the 5’- and 3’-ends are 
phosphorylated. They are unphosphorylated at both ends (34 and 42), 5’-phosphorylated (P34 
and P42), and 3’-phosphorylated (34P and 42P). These six RNAs, either alone or annealed in 
various combinations to form mimics of the cleaved tRNAAsp, were subjected to the reactions 
carried out by PfRlaP-NTase and PaRlaP-NTase in the presence of [- 32P]-ATP (Figure 2.8B). 
Single-stranded RNAs with either unphosphorylated or 5’-phosphorylated ends are effective 
substrates of both PfRlaP-NTase and PaRlaP-NTase (Figure 2.8B, lanes 2, 3, 5, and 6). On the 
other hand, single-stranded RNAs with 3’-phosphorylated ends are not substrates of PfRlaP-
NTase and PaRlaP-NTase (Figure 2.8B, lanes 4 and 7). These data indicate that effective RNA 
substrates of RlaP require the presence of 3’-OH group, but not 5’-OH group. Similar results 
were observed with the reactions employing the annealed Asp-34/Asp-42 RNAs as substrates. 
Specifically, RlaP-NTase only catalyzes reactions on RNAs that possess 3’-OH groups (Figure 
2.8B, Asp-34 in lanes 8 and 10, and Asp-42 in lanes 8 and 9). 
The requirement of 3’-OH group in RNAs to be effective substrates of RlaP indicates that, 
like other known families of NTases, RlaP likely catalyzes addition of 5’-NMP to the 3’-OH 
group of RNAs. This was further confirmed by the experiment of two-dimensional TLC 
analyzing nucleotides from the digested tRNAs (Figure 2.9). Judged by the mobilities of the 
products when compared to the size marker, RlaP-NTase adds one or two nucleotides to the 
RNA substrates (Figure 2.8B). This was further confirmed by MALDI-MS experiments of the 
RNA products from the reactions catalyzed by PfRlaP-NTase in a preparative scale (Figure 
2.10). The mechanism which prevents RlaP-NTase from adding more than two NMP at the 3’-
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end of an RNA substrate (e.g., RlaP acts as an RNA polymerase) is unknown and requires 
further investigation. 
Importantly, the relative reactivities of the same RNA substrate differ, depending on 
whether the RNA is alone or is part of a mimic of the cleaved tRNA. The reactivity of Asp-34 
increases significantly from the single-stranded RNA to the mimic of the cleaved tRNA (Figure 
2.8B, compare lanes 2, 3 to lanes 8, 10). On the other hand, the opposite is true for Asp-42 
(Figure 2.8B, compare lanes 5, 6 to lanes 8, 9). These observations indicate that RlaP-NTase 
possesses a certain degree of RNA substrate specificity. Specifically, when presented with equal 
opportunity to react in the substrate of 34/42, RlaP significantly prefers to catalyze the reaction 
on Asp-34 to Asp-42 (Figure 2.8B, lane 8). This result strongly suggests the involvement of 
RlaP-NTase in RNA repair in vivo, as the 3’-end of Asp-34 mimics one of the ends of damaged 
tRNA generated by colicin E5. Furthermore, when using a substrate which mimics tRNAArg 
cleavage by Colicin D which cleaves at a different position (Figure 2.11A), the results exhibited 
a similar pattern (Figure 2.11B, lanes 1-3 vs 4-6). The 5’ half, Arg-38, and the 3’ half, alone are 
poorer substrates than when they are annealed together. In the presence of both Arg-38 and Arg-
37, RlaP-NTase appears to prefer Arg-38. However, these results are less conclusive as Arg-38 
appears to have an unexpected mobility possibly due to folding of the substrate. Finally, 
comparison of reactions using Asp-34/Asp-42, tRNAAsp, and total RNA as substrates revealed 
that the bands in the total RNA reactions could be tRNA and cleaved tRNA, respectively (Figure 
2.12, right). The UV image shows that the cleaved tRNA bands are not well-represented, yet 
they are major products of RlaP-NTase reaction (Figure 2.12, left. This indicates that RlaP-




In vitro Reactions Using Synthetic DNAs and dNTP  
 To further probe the substrate specificity of RlaP-NTase, we carried out the reactions 
catalyzed by RlaP-NTase using synthetic DNAs as potential substrates. The rationale for the 
experiments was that, although E. coli genomic DNA was not shown to be the substrate of RlaP-
NTase (Figure 2.6), the negative result might stem from low availability of the 3’-OH end of 
DNA due to very large size of the genomic DNA. We thus purchased and purified two synthetic 
DNAs, D34 and D42, whose sequences are identical to the two synthetic RNAs we employed for 
our in vitro reconstitution (Figure 2.8A). These two synthetic DNAs, either alone (D34 and D42) 
or annealed with each other (D34/D42) were subject to the reactions catalyzed by RlaP-NTase in 
the presence of [-32P]-ATP (Figure 2.13, top panel). In addition to DNA substrates, we also 
employed DNA/RNA hybrids (42/D34 and D42/34) for the reactions, and RNA substrates (34, 
42, and 34/42) were used as the positive controls. Also, we tested the reactions with [-32P]-
dATP intead of [-32P]-ATP (Figure 2.13, bottom panel). 
As expected, all RNAs react with ATP (Figure 2.13, lanes 1, 3, and 5 of the top panel). On 
the other hand, no reaction was observed with DNA as substrates, whether D34 and D42 alone 
(Figure 2.13, lanes 2 and 4), or the annealed D34/D42 (Figure 2.13, lane 8). When a DNA is 
hybridized to an RNA, only the RNA strand reacts with ATP (Figure 2.13, lanes 6 and 7). We 
also carried out the same set of reactions in the presence of [-32P]-UTP instead of [-32P]-ATP 
and revealed that RlaP-NTase does not catalyze the reaction between synthetic DNAs and UTP 
(Figure 2.14). This is to confirm that the two minor products observed in the reaction between E. 
coli genomic DNA and [-32P]-UTP (Figure 2.6, lane 8) are not from E. coli genomic DNA. The 
experiments employing synthetic DNAs described here, together with the reactions using E. coli 
genomic DNA (Figure 2.6), clearly demonstrate that DNA is not the substrate of RlaP-NTase. 
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Surprisingly, RlaP-NTase is able to catalyze the reaction between RNAs and dATP 
efficiently (Figure 2.13, bottom panel). Although the overall pattern of the reactions between 
ATP and dATP is similar, there are some subtle differences in terms of substrate specificity. For 
example, dATP is more reactive than ATP with Asp-34 alone (Figure 2.13, lane 1), but less 
reactive with Asp-42 alone (Figure 2.13, lane 3). On the other hand, dATP is significantly more 
reactive than ATP with a degraded product of Asp-42 when Asp-42 is annealed to D34 (Figure 
2.13, lane 6, products marked with asterisk). Similar to ATP, RlaP-NTase does not catalyze 
reactions between synthetic DNAs and dATP. 
Optimization of in vitro Reaction Catalyzed by RlaP-NTase 
 At the early stage of our study, the in vitro reactions catalyzed by the recombinant RlaP-
NTase were sluggish, which prevented us from obtaining high quality products for MALDI-MS. 
We carried out our initial reactions employing Mg2+ because Mg2+ is the divalent ion preferred 
by most known NTases. To improve the efficiency of the reactions catalyzed by RlaP-NTase, we 
first screened various divalent ions and found that Mn2+ and Co2+ are significantly better than 
Mg2+ (Figure 2.15A, compare lanes 2 and 3 to lane 1). Zn2+ is also a better divalent ion compared 
to Mg2+ (Figure 2.15A, lane 6), but it is less effective than Mn2+ or Co2+, and the reaction is also 
less specific. Due to these observations, combined with the consideration that the physiological 
concentration of Mn2+ is significantly higher than Co2+ and Zn2+, we conclude that the in vivo 
activity of RlaP-NTase is likely to be Mn2+-dependent. This is very unusual among NTases as, to 
our knowledge, Mg2+ is the preferred divalent ion for other known NTases. We also carried out 





Aminoacylation of the Repaired tRNAAsp by Aspartyl-tRNA Synthetase (AspRS) 
 As the first step to test the hypothesis that RlaP-NTase might be required for restoring 
biological activity of excessively damaged RNAs, we performed aminoacylation assays of 
various repaired tRNAs, differing in their treatments by RlaP-NTase prior to RNA repair (Figure 
2.16). Thus, two annealed tRNAs, Asp-34/P42 and Asp-33/P42 that mimic tRNAAsp damaged by 
“ordinary” and “smart” ribotoxins, respectively, were treated with PfRlaP-NTase under various 
conditions (no NTP, GTP, and NTP). RNA repair was then carried out, and the repaired tRNAAsp 
were purified for aminoacylation assays. The repaired tRNAAsp from 34/P42, which should be 
the same as the wild-type tRNAAsp, was efficiently aminoacylated (Figure 2.16, 34/P42 column). 
The efficiency of aminoacylation of the repaired 33/P42 is less than 10% of the repaired 34/P42 
(Figure 2.16, 33/P42 column), demonstrating that tRNAAsp missing a nucleotide in the anticodon 
loop is a poor substrate of AspRS. Treatment of 33/P42 with RlaP-NTase in the presence of GTP 
prior to RNA repair results in significant increase of aminoacylation efficiency of the repaired 
tRNAAsp (Figure 2.16, 33/P42+GTP column), indicating that some of the repaired tRNA has 
been restored to the wild-type tRNA. Treatment of 33/P42 with RlaP-NTase in the presence of 
NTP mixture prior to RNA repair also increases the efficiency of aminoacylation by AspRS 
(Figure 2.16, 33/P42+NTP column). 
 The aminoacylation assay alone, however, has an inherent flaw as a functional assay of 
RlaP-NTase. For example, the repaired tRNA resulted from the treatment of 34/P42 with RlaP-
NTase in the presence of GTP showed approximately 20% increase in the aminoacylation 
efficiency by AspRS (Figure 2.16, 34/P43+GTP column), indicating that expanding the size of 
the anticodon loop of tRNAAsp from the standard seven nucleotides does not significantly affect 
its aminoacylation. But the repaired tRNA is likely to be less effective in protein translation. 
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Therefore, in addition to the aminoacylation assays described here, in vitro protein translation 
needs to be employed to test whether various aminoacyl tRNAs shown in Figure 7 are effective 
substrates of protein translation. It is our judgement that the in vitro protein translation assays are 
too complicated and too technically challenging for us to be accomplished in a timely fashion for 
this publication. 
Discussion of the functional role of RlaP-NTase 
 Based on the results of the study described here, we propose mechanisms of cell death 
and survival via RNA damage and repair, using a tRNA as an example, as schematically 
depicted in Figure 8. When a tRNA is damaged by an “ordinary” ribotoxin, a direct repair of the 
damaged tRNA is sufficient to produce biologically active repaired tRNA for cell survival 
(Figure 2.17, pathway 1). When a tRNA is damaged by a “smart” ribotoxin such as RloC (50), 
however, there are two distinct possible outcomes of RNA repair. In the absence of a RlaP-
NTase, a direct repair of a tRNA damaged by a “smart” ribotoxin would produce repaired, but 
biologically inactive tRNA, resulting in cell death (Figure 2.17, pathway 2a). If RlaP-NTase is 
present in the cell, RlaP-NTase will react with the damaged tRNA, and an RNA repair system 
will concurrently carry out RNA repair. The combination of these two activities result in 
heterogenous products of the repaired tRNA. The majority of the repaired tRNA is likely 
biologically inactive, as they either miss a nucleotide as shown in pathway 2a or the wrong 
nucleotide is incorporated by RlaP-NTase prior to RNA repair. However, a small portion of the 
repaired tRNA are expected to be biologically active due to restoration of the correct missing 
nucleotide by RlaP-NTase prior to RNA repair (Figure 2.17, pathway 2b). We envision this will 
allow the cell to have a chance of survival in emergency cases that require immediate action. The 
activity of RlaP-NTase would give the cell more time to initiate a more stringent cellular 
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response to deal with the root cause of the crisis: RNA damage by a “smart” ribotoxin. 
Interestingly, reaction of RlaP-NTase with a damaged tRNA by an “ordinary” ribotoxin is likely 
to reduce the population of active tRNA after repair. We speculate that when the cell is in crisis 
mode with the invasion of a ribotoxin, its primary goal is to survive and the quantity of active 
tRNA is unlikely to be the main concern. 
 There are two major inconsistencies which need to be addressed with the model that we 
present in Figure 2.17. First, we have shown here that RlaP-NTase requires a 3’-OH group as a 
substrate for NMP transfer. However, most ribotoxins cleave RNA in a manner that results in 3’-
P or 2’, 3’-cyclic P. For this, we have two responses 1) some ribotoxins such as VapC20 result in 
3’-OH and 2) preliminary data from our lab indicated that the 3’-P resulting from ribotoxin 
cleavage was not stable within a cell. Experiments performed in our lab have shown that isolated 
tRNAs which have been cleaved in vivo by ribotoxins Colicin D and Colicin E5 could not be 
repaired by RtcB in vitro. However, when tRNAs are isolated from E. coli cells then cleaved in 
vitro by the same ribotoxins, RtcB could carry out repair of these substrates. These initial results 
suggest that the 3’-P is removed in vivo, possibly due to hydrolysis or endogenous E. coli 
enzymes. If this data is correct, RlaP-NTase could utilize a ribotoxin-damaged RNA as a 
substrate. Further experiments on this subject are currently underway.  
 The second inconsistency is that PfRlaP-NTase and PaRlaP-NTase are both associated 
with RtcB. Previous studies on RtcB have all indicated that RtcB requires a 3’-P or 2’, 3’-cyclic 
phosphate for ligation. Our results showed that RlaP-NTase performs a standard addition of one 
or more nucleotides. Therefore, the product of RlaP-NTase reaction ends in 3’-OH which is 
inconsistent with repair by RtcB. However, many RlaP-NTases are associated with 5’-P ligases. 
We constructed a Gene Neighborhood Network (GNN) for RlaP-NTase and found that this 
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enzyme is associated with a variety of RNA repair systems including those with RtcB, Pnkp-
Hen1 5’-P ligase, T4-like 5’-P ligase, and with repair systems containing both 3’-P and 5’-P 
ligases (Figure 2.18). For 5’-P ligases, the product of RlaP-NTase reaction could be directly used 
for ligation. For operons containing RtcB and RlaP-NTase, it is possible that another protein 
which can phosphorylate the substrate is recruited. It could also be that some RtcB have the 
ability to ligate either 3’-P or 5’-P substrates. RtcB is a relatively newly discovered family of 
enzymes. Further experimentation is required to fully answer this inconsistency.  
 We have presented here a combination of bioinformatic, biochemical, and structural 
characterization of two NTases of the PF10127 family. One study of a large family of protein of 
unknown function, such as the PF10127 family, is unlikely to address all the issues. We envision 
that there are four main issues that need to be addressed in future studies. First, additional studies 
are required to provide further insight into the biological function of RlaP-NTase. Some type of 
in vivo study to test the interplays of a ribotoxin, RlaP-NTase, and an RNA repair system, would 
be ideal, but it is likely to be very complicated and the feasibility of the study is an issue. On the 
other hand, in vitro protein translation assays, built on our aminoacylation assays shown in 
Figure 2.16, might have a better chance to succeed. 
Second, the PF10127 family is composed of more than 6,000 members, and they show 
certain degrees of difference from one another as demonstrated by SSN shown in Figure 1A. 
Specifically, NTases in cluster 1a of SSN are likely to perform the same function as the two 
RlaP-NTases we have characterized. Less certain is the functions of NTases in clusters 1b and 
1c, and even more distant clusters 2-8 (Figure 2.1A). There are also other smaller clusters of 
eukaryotic NTases of the PF10127 family (Figure 2.1A, colored red), which are significantly 
larger (~600 a.a. on average) in size. We speculate, however, that NTases of the PF10127 family 
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are likely to perform the same enzymatic reaction. This is based on two observations. First, all 
members of NTases of the PF10127 forms a single cluster in SSN when plotted with E = 1e-10 
(Figure 2.2). Second, the active site appears to be highly conserved (Figure 3.2C). Nevertheless, 
future experimental characterization of NTases from clusters other than cluster 1a are required to 
reveal further insight into biochemical and biological functions of NTases of the PF10127 
family. Of particular interest, among NTases of unknown function of the PF10127 family, is 
NrdC.11 from bacteriophage T4 (Figure 2.1, marked with a magenta arrow) (112). As we have 
described before, the first RNA repair system, consisting of T4Pnkp and T4Rnl1, was discovered 
in bacteriophage T4 (39). If T4NrdC.11 performs the same function as two RlaP-NTases 
described in this study, then then RNA repair carried out by bacteriophage T4 is more capable 
and sophisticated than we previously thought. 
Third, from an enzymatic point of view, RlaP-NTase appears to be in a position between 
Pol-NTase and CCA-adding enzyme. Like Pol-NTase, RlaP-NTase shows little substrate 
specificity for NTP and dNTP. On the other hand, unlike Pol-NTase, RlaP-NTase only adds 
one or two NMP at the 3’-end of RNA. This limited addition of NMP by RlaP-NTase is more 
similar to the CCA-adding enzyme, which only adds three nucleotides to the 3’-end of tRNAs. 
RlaP-NTase can also be compared to Thg1 (113,114). With the exception that they operate at the 
opposite ends (3’-end versus 5’-end) of RNA, both of them have limited addition of NTP to 
RNAs. In addition, they might also be functionally related because, although less frequently, the 
gene encoding Thg1 has also been found in the same operon as RNA ligases (82). 
Finally, we were curious with the unexpected observation that, unlike most known NTases, 
RlaP-NTase is Mn2+-dependent. In addition to RlaP-NTase, we also found that, with the 
Pnkp/Hen1 RNA repair system, the phosphatase activity of Pnkp and the methyltransferase 
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activity of Hen1 also require Mn2+ (65,76). Furthermore, bacterial RtcB, which is ubiquitous and 
presumably involved in RNA repair, also requires Mn2+ for catalysis. Further investigations are 
required to reveal whether these observations are just coincidence, or Mn2+ is used for additional 
regulation by cells in response to stress caused by RNA damage and repair. 






























































Table 2.2. E. coli optimized gBlock sequences. The gBlock gene fragments were purchased from 
IDT for cloning of His-tagged RlaP-NTase into pET-Duet-1. Restriction enzymes BamHI and NotI 


















Table 2.3. Primers used for amplification of Non-tagged RlaP-NTase from gBlock. Primers 












Figure 2.1. Distribution and gene neighborhoods of RlaP-NTase. (A) Sequence similarity 
network (SSN) of NTases of the PF10127 family. The network of 70% representative node (e.g., 
sequences that share 70% or more identities are grouped in the same metanode) was shown here 
in order to save space. The locations of two RlaP-NTases employed in this study are marked 
with orange arrows. And the location of the NTase of unknown function from bacteriophage T4 
is marked with a magenta arrow. (B) Schematic view of the genes encoding two RlaP-NTases 
and their neighboring genes in the operons. Only the genes of RlaP-NTases and those involved in 






Figure 2.2. SSN is the same network as one shown in Fig. 1A except that it was calculated and 
displayed with Ecutoff =1e-10. At Ecutoff =1e-10, all nodes are included in a single cluster, 















Score    Expect Identities Positives  Gaps 
323 bits(828) 1e-116  166/266(62%)  199/266(74%)  4/266(1%) 
PfRlaP-NTase 1   MQREERHPLSDAMRARVAQELDRIERERNVKVLYACESGSRAWGFASTDSDYDVRFVYVE  60 
                 M REERHPL  AMR RV  EL+RIERE +V VLYACESGSRAWGFAS DSDYDVRFVYV  
PaRlaP-NTase 1   MNREERHPLPAAMRERVLDELERIEREHDVVVLYACESGSRAWGFASPDSDYDVRFVYVH  60 
 
PfRlaP-NTase 61  KPDWFMQVDAPRDVIERPLDDELDVSGWELRKTLGLLRKSNPTLLEWLDSPLVYRQQTEA  120 
                 +P+W+ +V+ PRDVIERPL DELD+SGWELRK L L+RKSNP LLEWL SPLVYR++    
PaRlaP-NTase 61  QPEWYQRVEEPRDVIERPLSDELDISGWELRKALRLMRKSNPALLEWLGSPLVYREEPGV  120 
 
PfRlaP-NTase 121 TAQLRALAEAFYSPPAARNHYLSMARKNFRGYLQGETVRFKKYFYVLRPLLAVRWIDLGL  180 
                   +L  L  AF+S P +R+HYLSMARKN+RGYL+G++VR KKY YVLRPL AVRW+D GL 
PaRlaP-NTase 121 REELLWLGSAFHSVPGSRHHYLSMARKNYRGYLKGDSVRLKKYLYVLRPLFAVRWLDAGL  180 
 
PfRlaP-NTase 181 GRPPMTFADLL-STVSDAPLLDEVATLLALKRNAGEAAYGPRRPALHAFIVAEL---ERE  236 
                 G PP+ F  L+ +T+ D  L +E+  LL+LKR   E+AYGP R AL  FI AEL   ER  
PaRlaP-NTase 181 GLPPVAFERLVEATLDDPSLREELDALLSLKRQRDESAYGPPRLALQRFIEAELLQAERG  240 
 
PfRlaP-NTase 237 VPVLPRTREDSQRLDRYLRDTVKRFA  262 
                        R+DS+ LDRYL D + ++  
PaRlaP-NTase 241 ATQPTGARQDSRLLDRYLHDKIWQYT  266 
 
Figure 2.3. Conservation between PfRlaP-NTase and PaRlaP-NTase. The amino acid sequences of 
PfRlaP-NTase and PaRlaP-NTase were aligned, revealing 62% sequence identities between them. The 
conserved motifs of NTases, [GS], [D]h[D], and h[D]h (h represents hydrophobic residues), are in bold, 







Figure 2.4. Expression and purification of the recombinant PfRlaP-NTase and PaRlaP-NTase. 
Both proteins were expressed well in E. coli (lane 3). However, while more than half of the 
expressed PfRlaP-NTase are soluble protein (lane 6 of the gel on the left panel), the 





Figure 2.5. Several E. coli RNAs are substrates of RlaP-NTase. In vitro reactions of total E coli 
RNAs and [-32P]-NTP were carried out without and with the presence of PfRlaP-NTase (A) and 
PaRlaP-NTase (B). 
 



















8. Gel filtration loading
9. Gel filtration





Figure 2.6. E. coli DNA is not the substrate of RlaP-NTase. Genomic DNA isolated from E. coli 
cells was reacted with [-32P]-NTP in the absence (lanes 1, 3, 5, and 7) and presence (lanes 2, 4, 





Figure 2.7. E. coli proteins are not the substrates of RlaP-NTase. Proteins isolated from E. coli 
cells were reacted with [-32P]-NTP in the absence (lanes 1, 3, 5, and 7) and presence (lanes 2, 4, 
6, and 8) of PfRlaP-NTase (A) and PaRlaP-NTase (B). Weak radioactive bands corresponding to 
the mobility of RlaP-NTase were observed in lanes 2, 4, 6, and 8, indicating possible formation 
of small amount of covalent complex of RlaP-NTase and NMP. The identity of RlaP-NTase, not 
an E. coli protein, was confirmed with the reactions in the absence of E. coli proteins (data not 
shown). In addition, an unknown molecule was radiolabeled (marked with a question mark). 
Because it is also present in the lanes lacking RlaP-NTase, we suggest that its formation is 






Figure 2.8. In vitro reconstitution of the enzymatic activity of RlaP-NTase using synthetic RNAs 
as substrates. (A) Sequences of two synthetic RNAs, which match the sequences of 5’- and 3’-
halves of tRNAAsp resulting from the cleavage by ribotoxin colicin E5. The nucleotides 
belonging to the anticodon of the tRNA are shaded gray. (B) DPAGE analyses of the reactions 
catalyzed by RlaP-NTase using various combinations of RNAs shown in A as substrates in the 












Figure 2.9. Confirmation of the addition of 5’-GMP to the 3’-OH group of RNA substrate by 
RlaP-NTase. (A) 2D TLC of the digests of the in vitro transcribed tRNAGln. tRNAGln was 
transcribed in the presence of [-33P]-NTP, resulting in radioactivity of all four nucleotides in 
tRNA. (B) 2D TLC of the digests of the same tRNAGln as in (A), but with the additional reaction 
with [-33P]-GTP catalyzed by PfRlaP-NTase before the enzymatic digestion. Co-elution of 5-
GMP from two sources of tRNA digests indicates that RlaP-NTase adds NMP to the 3’-OH 







Figure 2.10. MALDI-MS spectra of the reaction products of Asp-34 RNA. 15 M of Asp-
34/Asp-42 RNA was incubated with 7.5 M of PfRlaP-NTase at 25 ºC in the absence of ATP 
(A), in the presence of 60 M ATP (B), and in the presence of 150 M ATP (C). After 60 min of 
the reaction, RNA was purified with DPAGE. The recovered Asp-34 RNA was dissolved in 
water and subject to MALDI-MS experiments. The calculated m/z of Asp-34, Asp-34•AMP, and 







Figure 2.11. In vitro reconstitution of RlaP-NTase activity using synthetic cleaved tRNAs. (A) 
Synthetic RNAs, Arg-38 and Arg-37, designed to mimic the 5’ and 3’ halves of tRNAArg cleaved 
by Colicin D, respectively. (B) DPAGE analysis of reactions with PfRlaP-NTase and Asp-34, 






Figure 2.12. RlaP-NTase reaction with synthetic substrates and isolated RNA. PfRlaP-NTase 
was incubated with Asp-34/Asp-42, tRNAAsp, or total RNA isolated from E. coli in the presence 
of MnCl2, a mixture of all four NTPs, and [-
32P]-GTP. The reactions were analyzed by 
DPAGE. UV light was used to visualize RNA (left) and a phospor-imaging plate was used to 







Figure 2.13. In vitro assays of the enzymatic activity of PfRlaP-NTase using both synthetic 
DNAs and RNAs as substrates in the presence of [-32P]-ATP (top panel) and [-32P]-dATP 
(bottom panel). The bands marked with asterisk are likely the reaction product of the degraded 




Figure 2.14. Assays of potential reactions of synthetic DNAs with [-32P]-UTP in the presence 
of PfRlaP-NTase. The reaction conditions are identical to those shown in Fig. 4, top panel, with 







Figure 2.15. Optimization of the in vitro reactions carried out by RlaP-NTase. (A) Analysis of 
the reactions catalyzed by RlaP-NTase in the presence of different divalent ions. (B) The 
efficiency of the reactions catalyzed by PfRlaP-NTase at different pH. The annealed 34/42 RNA 





Figure 2.16. Efficiency of aminoacylation of various repaired tRNAs by AspRS. The repaired 
tRNAAsp from 34/P42, which should be the same as the wild-type tRNAAsp, was used as the 
positive control, and the efficiency of its aminoacylation was normalized to 100%. All other 
assays were calculated as the efficiency relative to the one of the repaired 34/P42. The number of 








Figure 2.17. Proposed biological function of RlaP-NTase. Schematic view of a tRNA cleaved by 
ribotoxins, followed by RNA repair without or with the involvement of RlaP-NTase. The 






Figure 2.18. Summary of the Gene Neighborhood Network of RlaP-NTase. RlaP-NTase was 
found to be in a variety of RNA repair operons including those containing (A) RtcB, (B) Pnkp-
Hen1 repair systems, (C) T4-like repair systems, (D) repair systems containing both 3’-P and 5’-










CHAPTER 3: STRUCTURAL STUDIES OF PFRLAP-NTASE 
 
3.1 Introduction 
 Members of the Polβ superfamily little or no sequence homology outside of a highly 
conserved NTase domain (83). Members of this superfamily contain variety of enzymatic, binding, 
and structural domains which allow this family to perform a wide range of biological functions on 
vastly different substrates. Yet, the core NTase domain links this superfamily together. The NTase 
fold domain consists of three β-sheets flanked by four α-helices (89) (Figure 1.9). The β-sheets 
contain three highly conserved negatively charged residues which are typically aspartic acid but 
sometimes the third one is glutamic acid. The catalytic aspartic acid residues are responsible for 
activating the acceptor hydroxyl group on the substrate and coordinating two divalent metal ions 
(Figure 1.10) (90). The metal ions are involved in stabilizing the transition state, activating the 3’-
OH group to conduct a nucleophilic attack, and stabilizing the pyrophosphate leaving group. We 
solved the structure for PfRlaP-NTase at 2.1 Å and present our findings here.  
3.2 Materials and Methods 
Purification of PfRlaP-NTase- 
 PfRlaP-NTase for use in crystallization was expressed and purified as previously 
described with the exception that the sample was further purified by Superdex200 size exclusion 
chromatography (10 mM HEPES pH 7, 400 mM NaCl and 2% glycerol). Purified PfRlaP-NTase 





Protein Crystallization, Data Collection, and Structure Determination  
 PfRlaP-NTase was crystallized using hanging drop vaporization by mixing PfRlaP-
NTase (5-6 mg/mL) with the well solution (in 1:1 ratio) containing 1.2-1.6 M sodium malonate, 
pH 6.5- 7.5, at 18 oC. Crystals were briefly soaked in cryoprotection solution containing 1.5 M 
sodium malonate and 20% glycerol followed by the same solution with 40% glycerol. The cryo-
protected crystals were then mounted and flash-frozen in liquid nitrogen. Native and single-
wavelength anomalous dispersion (109) data were collected at the 21-ID beamlines at the 
Advanced Proton Source (APS). Data were processed using the HKL2000 program (116). Phase 
was determined based on selenomethionine single-wavelength anomalous diffraction data using 
the Phenix program (117). A partial model was automatically built using Phenix. The remaining 
model was manually built using the Coot program (118). Refinement was done using Phenix. 
3.3 Results and Discussion 
Crystal Structure of PfRlaP-NTase 
 We crystallized and solved the structure of PfRlaP-NTase at 2.1 Å resolution (Figure 3.1 
and Figure 3.2). The overall fold of PfRlaP-NTase can be depicted as the N-terminal NTase 
domain (Figure 3.1, colored red) fused with the C-terminal helical domain (Figure 6A, colored 
blue). The interaction of these two domains is further reinforced by the helix at the very C-
terminus of the enzyme (Figure 3.1, colored green), which joins the two helices from the N-
terminal NTase domain to form a three-helix bundle. The overall fold of RlaP-NTase results in 
formation of a cleft between the N-terminal NTase domain and the C-terminal helical domain 
(Figure 3.1 C, D), where the RNA substrate and NTP presumably meet for the transfer reaction 
of NMP from NTP to the 3’-OH group of RNA. Although Mg2+ or Mn2+ were present in the 
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crystallization solution, they were not observed in the final structure. Therefore, the NTP binding 
pocket shown in Figure 3.1B is negatively charged, mainly reflecting the three strictly conserved 
aspartic acids required for catalysis. On the other hand, the bottom of the cleft, where the RNA 
substrate presumably binds, is mainly positively charged, (Figure 3.1B, bottom).  
 These assessments are consistent with the distribution of amino acid conservation of 
RlaP-NTase on the structure, which shows that the residues within the cleft are most conserved 
(Figure 3.2). In addition to the lack of divalent metal ions in the structure, attempts to include an 
NTP into the structure, either by co-crystallization or soaking, were also unsuccessful. We 
speculate that the high salt of the crystallization condition might prevent NTP from staying in the 
NTP binding pocket during crystallization or soaking. Alternatively, RlaP-NTase might require 
the binding of RNA substrate first in order to accommodate for an NTP for catalysis. We created 
a docking model with both UTP (Figure 3.3, left) and GTP (Figure 3.3, right). The model 
predicted that both pyrimidine and purine bases fit into the NTP binding pocket. Furthermore, 
the three highly conserved catalytic aspartic acid residues are in position to coordinate divalent 
metal ions which activate the substrate to attack the α-phosphate and stabilize the pyrophosphate 
leaving group.  
 A Dali structural search of PfRlaP-NTase revealed that is structurally related to 
adenylyltransferases. The top two hits were aminoglycoside/streptomycin adenylyltransferases 
(Figure 3.4A) and glutamate-ammonia-ligase adenylyltransferases (Figure 3.4B). 
Aminoglycoside/streptomycin adenylyltransferases are involved in antibiotic resistance in 
bacteria (119). This family of enzymes has the top Z score (9.3-9.7) from the Dali search but a 
low rmsd (4.4-4.8 Å) and shares only 8-10% sequence identities with RlaP-NTase. Glutamate-
ammonia-ligase adenylyltransferases play a role in the regulation of glutamine synthetase (120). 
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This class of enzymes has slightly lower Z score (8.3-8.7) but a better rmsd (3.8-4.0 Å) and 
sequence identities (13-14%). Based on these three parameters, we conclude that RlaP-NTase 
shares only modest structural and functional similarities to these two classes of enzymes.  
 A separate Dali search was performed based on the N-terminal NTase domain (residues 
2-132) and C-terminal helical domain (residues 133-243), respectively. 
Aminoglycoside/streptomycin adenylyltransferases were among the top scores for the NTase 
domain. The results for the C-terminal domain were more diverse. Interestingly, the top hit for 
both searches yielded the same result- a protein of unknown function, Bacillus YgxA 
(unpublished, PDB accession code: 3C18). Structural aligments of YgxA with the N-terminal 
(Figure 3.5A) and C-terminal (Figure 3.5B) domain of RlaP-NTase revealed good alignments 
with the individual domains but not with the overall structure. Additionally, despite the structural 
similarities, the sequence identities between RlaP-NTase and YgxA are low- 6% for the N-
terminal NTase domain and 9% for the C-terminal helical domain. Therefore, we conclude that 
RlaP-NTase is only moderately similar to YgxA. Based on our overall Dali results, we believe 









3.4 Table and Figures 
PfRlaP-NTase 
Data Collection  
Space Group P212121 
Cell dimensions 
    a, b, c (Å) 
       (°) 
 
 
51.3, 69.7, 192.6 
90.0, 90.0, 90.0 
Resolution (Å) 50.0-2.1 (2.14-2.10) 
Rmerge (%) 6.4 
I/ 11.1 (5.2) 




Resolution (Å) 47.2-2.1 (2.18-2.1) 
No. reflections 40,128 (4,020) 
Rwork/Rfree (%) 19.0/22.1 (19.4/22.7) 
No. atoms 
    Protein 




Average B factors (Å2) 
    Protein 
    Water  
 
33.4 
38.8 R.m.s. deviations 
    Bond lengths (Å) 




Ramachandran statistics (%) 
    Favored 
    Allowed 




0.0 *Values in parenthesis are for highest resolution shell. 





Figure 3.1. Structure of PfRlaP-NTase. (A) Carton representation of the structure of PfRlaP-
NTase viewed from the top. The N-terminal NTase domain is colored red, the C-terminal helical 
domain is colored blue, and the very C-terminal helix joining the NTase domain is colored green. 
Three aspartic acids, required for the reaction and conserved in all NTase, are in stick and 
colored black. (B) Surface representation of the structure in the same view as in A. The structure 
is colored by surface charge, with negative charge in red, positive charge in blue, and neutral in 
white. (C) The side view of the same structure as in A. (D) The surface representation of the 









Figure 3.2. Amino acid conservation of NTase of the PF10127 family depicted on the structure 
of PfRlaP-NTase. The structure of PfRlaP-NTase was displayed and oriented the same as in 
Figure 6B and Figure 6D except the structure was colored based on amino acid conservation. 
The amino acid conservation in (A) and (B) was calculated based on the representative 
sequences from cluster 1a of SSN shown in Fig. 1. On the other hand, the conservation shown in 







Figure 3.3. Docking model of UTP and GTP in NTP binding site. Attempts to obtain a co-
crystal structure with NTP were unsuccessful. Therefore, we present a docking model of UTP 
(left) and GTP (right) in the NTP binding pocket of our PfRlaP-NTase structure. Both NTPs fit 
into the pocket. The amino acid residues are colored according to conservation as in Figure 3.2 
C-D. The three aspartic acid residues are in position to coordinate divalent metal ions which 






Figure 3.4. Dali search of RlaP-NTase. Comparison of our PfRlaP-NTase structure to the Dali 
network revealed the top two hits were aminoglycoside/streptomycin adenylyltransferases (A) 
and glutamate-ammonia-ligase adenylyltransferases (B). However, based on Z score, rmsd, and 
sequence identities (8-10% for (A) and 13-14% for (B)), we conclude that RlaP-NTase shares 
only moderate similarities to these two classes of enzymes.  
Z score = 9.7, rmsd = 4.4 Å






Figure 3.5. Dali search for RlaP-NTase domains. A) Dali search for only the N-terminal NTase 
domain of PfRlaP-NTase revealed the best alignment was with a protein of unknown function, 
Bacillus YgxA. B) Dali search with the C-terminal helical domain of RlaP-NTase also obtained 
YgxA as the top hit. Despite the structural similarities, YgxA shares only 6% and 9% sequence 
identity with the N-terminal NTase domain and C-terminal domain of RlaP-NTase, respectively.  
Z score = 9.5, rmsd = 3.1 Å





CHAPTER 4: STRUCTURAL AND BIOCHEMICAL STUDIES OF A NOVEL 
RIBOTOXIN, PA-CD, AND ITS IMMUNITY PROTEIN, PA-IMMUNITY 
 
4.1 Introduction 
 In an environment with limited resources, organisms, microbes in particular, must employ 
a variety of offensive and defensive mechanisms to ensure their own survival and growth. 
Therefore, many organisms utilize ribotoxins as tools for responding to cellular stress and for 
killing competing or invading organisms. Ribotoxins cleave RNA in a site-specific manner and 
most ribotoxins target RNAs that are important for translation: tRNAs, rRNAs, and mRNAs. Most 
ribotoxins inhibit translation through the inactivation of these RNA molecules, resulting in arrest 
of cell growth and eventually cell death. A cell may secrete a ribotoxin for the purpose of killing 
a competing organism. Many cells also use ribotoxins to inhibit their own growth such as during 
times of nutritional stress to conserve resources or when invaded by a virus for the purpose of 
restriction.  
 A growing number of ribotoxins have been identified as tRNases or ribotoxins which 
cleave tRNAs in their anticodon loop. PrrC is a bacterial toxin expressed in response to T4 
infection and cleaves tRNALys (39). Colicins E5 and D have been reported to excise specific tRNAs 
between bases 34 and 35 and 38 and 39, respectively (3,16). Many members of the VapC family 
also target tRNAs (27). Most bacterial toxin loci also encode for an immunity or antitoxin protein 
which protects the toxin-producing cell from susceptibility to the toxin. Colicins form tightly-
bound 1:1 heterodimer complexes with their cognate immunity proteins (121). Crystal structures 
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of colicin D with its immunity protein, ImmD, have shown that ImmD completely blocks colicin 
D’s active site by mimicking its tRNA substrate backbone (122).  
 Though many ribotoxins have been identified by bioinformatics, only a handful have been 
thoroughly characterized. Recently, Aravind and coworkers used a combination of comparative 
genomics, sequence, structural analysis to identify and characterize both known and predicted 
bacterial toxins and their immunity proteins (14). Based on this study, our lab cloned and expressed 
a subset of these predicted ribotoxins in E. coli and tested for toxicity. One candidate that 
significantly impaired cell growth was pseudomonas aeruginosa colicin D-like (Pa-CD) named 
due to its predicted similarity to colicin D. Our lab chose to further study Pa-CD and its immunity 
protein, Pa-Imm, to determine its mode of action for cell killing and its cellular target. Our studies 
show that Pa-CD is a ribotoxin which excises tRNAs in a similar manner to colicin D except with 
a distinct subset of tRNA targets.  
4.2 Materials and Methods 
General Materials and methods 
 Plasmids containing Pa-CD/pBAD and Pa-Imm/pQE-160 with E. coli codon-optimized 
sequences were provided by Dr. Pei Wang. All primers and templates were purchased from IDT. 
All plasmid sequences were confirmed by sequencing at the Roy J. Carver Biotechnology Center 
at UIUC. DH5α competent cells were obtained from Sandy McMasters at the cell media facility 
at UIUC. Initial growth assays, RNA-Seq and northern blotting assays were performed by Dr. 





Molecular cloning of Pa-CD and Pa-Imm: 
  Pa-CD and Pa-Imm were amplified from Pa-CD/pBAD and Pa-Imm/pQE-160, 
respectively using Phusion HF polymerase (Figure 4.1 and Figure 4.2). Pa-Imm insert and 
pETDUET-1 (Novagen) were digested with restriction enzymes and then gel purified using a gel 
extraction kit (Qiagen). T4 DNA ligase was used to insert Pa-Imm into MCS2 (multiple cloning 
site) of pETDUET-1. The plasmid was transformed into DH5α and the resulting Pa-
Imm2/pETDUET-1 plasmid was isolated using a miniprep kit (Qiagen). Pa-CD insert and Pa-
Imm2/pETDUET-1 plasmid were digested with restriction enzymes, gel purified, and ligated 
together into two constructs- Pa-CD1-His6/Pa-Imm2/pETDUET-1 (Pa-CD in MCS1 with His6 tag 
and Pa-Imm in MCS2) and Pa-CD1/Pa-Imm2/pETDUET-1 (Pa-CD in MCS1 without tag and 
Pa-Imm in MCS2). The ligated plasmids were transformed into DH5α, confirmed via sequencing, 
and transformed into BL21(DE3) cells (Invitrogen) for protein expression.  
Expression and Purification of Pa-CD/Pa-Imm complex 
 Small volumes of LB media were inoculated with BL21 colonies containing Pa-CD1-
His6/Pa-Imm2/pETDUET-1 or Pa-CD1/Pa-Imm2/pETDUET-1 and shaken overnight at 37 
oC. 
The starter cultures were used to inoculate 1L LB containing 100 µg/mL ampicillin. The cultures 
were shaken at 37 oC until OD=0.4-0.6. Expression of the plasmids was induced by addition of 
500 µM IPTG and the cells were returned to shake at 37 oC for an additional 4 hours. Cells were 
harvested by centrifugation and the pellets were flash-frozen and stored at -80 oC.  
 Pa-CD1-His6/Pa-Imm2/pETDUET-1 cells were resuspended in Ni A buffer (20 mM Tris, 
pH 8, 100 mM NaCl) and lysed by French press and the supernatant was isolated by centrifugation. 
Recombinant Pa-CD-His6/Pa-Imm complex was purified by FPLC using His affinity (Ni A and 
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Ni B (20 mM Tris, pH 8, 100 mM NaCl, 500 mM imidazole)), Heparin affinity (DEAE A (20 mM 
Tris pH 8, 10 mM NaCl, 2% glycerol) and DEAE B (20 mM Tris, pH 8,  1 M NaCl, 2% glycerol)), 
MonoQ ion exchange (DEAE A and DEAE B) and Superdex-200 size exclusion (Gel filtration 
buffer (10 mM HEPES pH 7, 200 mM NaCl, 2% glycerol) chromatography.  
 Pa-CD1/Pa-Imm2/pETDUET-1 cells were resuspended in DEAE A buffer, lysed by 
French press, and centrifuged to isolate the supernatant. Pa-CD/Pa-Imm complex was purified 
first by DEAE ion exchange (DEAE A and DEAE B) then by Heparin affinity (DEAE A and 
DEAE B). The eluted heparin fractions were run through MonoQ (DEAE A and DEAE B) ion 
exchange to get rid of excess Pa-Imm. The MonoQ flow through was then run through MonoQ 
again to retain Pa-CD/Pa-Imm complex. The recombinant protein complex is further purified 
using Superdex-200 size exclusion (Gel filtration buffer) chromatography. Protein samples were 
analyzed by 20% SDS PAGE.  
Separation of Pa-CD from Pa-Imm 
 Pa-CD1-His6/Pa-Imm2/pETDUET-1 cells were lysed in Ni A and the supernatant was 
obtained as described previously. The Pa-CDHis6/Pa-Imm complex was isolated using Ni affinity 
chromatography (Ni A and Ni B). The complex was denatured by slowly buffer exchanging to Ni 
A+ 6 M urea. The denatured sample was heated for 30 min at 80 oC and the proteins were separated 
by Ni affinity column (Ni A + 6 M urea and Ni B +6 M urea). The proteins were refolded via 
dialysis in 3.5 kDa Midi D tube dialyzers (Millipore). Dialysis was performed step-wise by 
dialyzing against each of the following solutions for 1.5 hours: Ni A +3 M urea, Ni A +1.5 M urea, 
Ni A +500 mM urea, Ni A +150 mM urea, and Ni A. The refolded proteins were further purified 
using MonoQ ion exchange chromatography (DEAE A and DEAE B). The Pa-CD1/Pa-
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Imm2/pETDUET-1 complex was separated in a similar manner except with the use of DEAE A 
and B +6 M urea and MonoQ column for separation of the denatured complex. 
Crystallization of Pa-CD/Pa-Imm complex 
 Purified Pa-CD/Pa-Imm complex was crystallized using hanging drop vaporization at 18 
oC. Equal volumes of purified Pa-CD/Pa-Imm (6 mg/mL) and well solution were mixed together. 
The best crystals were obtained with well solution containing 100 mM sodium citrate pH 5.3-5.9 
and 1.4-2.0 M ammonium sulfate. Crystals took at least 8 months to form. Crystals were briefly 
soaked in cryo-protection solution containing 100 mM sodium citrate H 5.5, 1.8 M ammonium 
sulfate, and 30% glycerol then mounted and sent to Advanced Photon Source (APS) for diffraction.  
Heavy atom soaking of Pa-CD/Pa-Imm crystals 
 1µL of the following heavy atom solutions were added to a glass cover slide: 1 or 2 mM 
methyl mercury chloride or 2 mM K2PtCl4. Crystals were transferred to the soaking solutions and 
200 µL of 100 mM sodium citrate pH 5.5 and 2 M ammonium sulfate was added to the wells. The 
crystals were left to soak for either 2 or 6 hours before being transferred to the same cryoprotection 
solution as above. The crystals were soaked for five minutes in cryoprotection solution then 
mounted and sent to APS.  
Quikchange mutagenesis and crystallization of s-met Pa-CD/Pa-Imm 
 Pa-CD/Pa-Imm methionine mutants were generated using a Quikchange site-directed 
mutagenesis kit (Stratagene) with the primers shown in Table 4.1. Each mutant had a single residue 
mutated to methionine in both Pa-CD and Pa-Imm. E. coli strain Rosetta was used to incorporate 
selenomethionine (s-met) into Pa-CD/Pa-Imm or Pa-CD-His6/Pa-Imm. The resulting S-met Pa-
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CD/Pa-Imm and s-met Pa-CD-His6/Pa-Imm complexes were purified and crystal trays were set 
out as previously described. 
In vitro transcription of Pa-CD tRNA targets 
  Templates and primers for in vitro transcription of E. coli tRNAGln1, tRNAGln2, and tRNAHis 
were purified using 8% DPAGE, crush and soak method, and ethanol precipitation (Table 4.2). 
The pellets were resuspended in TE pH 8. The templates and primers were annealed together by 
heating at 95 oC for 3 min then cooling slowly to 25 oC. In vitro transcription reactions containing 
0.1 µM template/primer, 1 µM T7 RNA polymerase, 1.25 mM each NTP, and 5 mM DTT were 
set up in T7 buffer (40 mM Tris-HCl pH 7.9, 6 mM MgCl2, and 2 mM spermidine). Reactions 
were incubated at 37 oC overnight and the resulting tRNA was purified by 10% DPAGE, crush 
and soak method, and ethanol precipitation. RNA pellets were resuspended in DEPC-treated water 
and stored at -80 oC.  
Pa-CD activity assays 
 In vitro Pa-CD activity assays were carried out in Cleavage buffer (40 mM Tris-HCl pH 
8, 70 mM NH4Cl, and 2 mM MgCl2). Purified Pa-CD and tRNA substrate were mixed in the 
indicated ratios (concentration of RNA is dependent on size of gel, 1-2 µM for small gels, 5-10 
µM for large, thick gels). Reactions were incubated at 37 oC for the indicated time. Reactions were 
denatured by addition of DPAGE loading buffer (50% formamide and 1 mM EDTA), heated for 
3 min at 95 oC then analyzed by 10% DPAGE. RNA was observed either by UV light or staining 





4.3 Results and Discussion 
Pa-CD is an active ribotoxin which inhibits cell growth 
 To determine whether Pa-CD was toxic to cells, E. coli strain MG1165 cells were 
transformed with Pa-CD/pBAD (arabinose-inducible) and Pa-Imm/pQE-160 (IPTG-inducible) 
(Figure 4.3). Induction of Pa-CD/pBAD (red) resulted in inhibition of cell growth compared to 
non-induced cells (black). Induction of both Pa-CD/pBAD and Pa-Imm/pQE-160 (blue) or Pa-
Imm/pQE-160 alone (green) did not show a significant growth defect compared to non-induced.  
These results indicate that Pa-CD has some toxic effect and that expression of Pa-Imm contradicts 
the effect of Pa-CD.  
The targets of Pa-CD cleavage are tRNAHis, tRNAGln1, and tRNAGln2 
 To determine whether Pa-CD is a ribotoxin, we developed an RNA-seq based method to 
determine the RNA targets of novel ribotoxins. This methodology is based on the approach used 
by Nickels and coworkers to determine the targets of MazF-mt3 cleavage (37). An overview of 
our experimental design is shown in Figure 4.4. An unmodified pool of cellular RNA contains a 
specific set of RNAs with either triphosphate or monophosphate at its 5’ end. Upon exposure to a 
ribotoxin, new 5’ ends will be created with either 5’-P or 5’-OH depending on the mechanism of 
the ribotoxin (Figure 4.4, A).  The experimental steps to generate four distinct data sets are 
summarized in Figure 4.4, B. The most critical step is the ligation of a universal adaptor to the 5’ 
end of the RNAs. This ligation is performed by a 5’-P ligase which can only add the adaptor to 5’-
P ends. Three important pieces of information can be gained from this data: i) the difference 
between data sets 3 and 1 (subtracting 3-1) or 4 and 2 will identify the location of any new 5’ ends 
resulting from toxin expression and thus, the target of the ribotoxin; ii) the RNA-seq reads of the 
79 
 
newly-generated 5’ ends will determine the exact nucleotide position of the cleavage; and iii) 
comparison of the difference between 3-1 and 4-2 would determine whether RNA cleavage 
resulted in 5’-P or 5’-OH terminus, providing information about the mechanism of the toxin.  
 The validity of our RNA-seq method was tested using the well-studied ribotoxin, VapC20. 
RNA samples from cells with or without expression of VapC20 were treated as described in Figure 
4.4, B. Figure 4.5 shows the results of data set 1 (A) and data set 3 (B), and the difference between 
3 and 1 (C). The results indicate that the target for RNA cleavage is the 23S rRNA gene between 
nucleotides 2561 and 2562 (D). This data agrees with previous studies which have shown that 
VapC20 cleaves the SRL at the same position as sarcin (E) (5). Furthermore, the fact that the 3-1 
is the same as 4-2 (data not shown) indicates that VapC20 cleavage results in 5’-P as previously 
reported.  
 Once our methodology had been validated, Pa-CD was tested.  The subtraction of Pa-CD 
data sets 2 from 4 showed that the genes for 3 tRNAs- tRNAHis, tRNAGln1, and tRNAGln2- had new 
5’ ends generated as a result of exposure to Pa-CD (Figure 4.6, A-C). The sequencing data showed 
that these three tRNAs were cleaved between nucleotides 38 and 39 in the anticodon loop which 
is the same site as colicin D cleavage. Interestingly, the three tRNA targets contain the sequence 
UGAU at positions 35-38 and are the only tRNAs with that sequence in the E. coli genome. 
Cleavage resulted in 5’-OH termini. After identifying the targets of Pa-CD by RNA-seq, the results 
were verified using in vivo cleavage assays involving expression of Pa-CD in MG1655 cells, 
isolation of tRNA, and northern blotting with probes for each specific tRNA (Figure 4.7). Cleaved 
tRNA can be seen with probes for tRNAHis, tRNAGln1, and tRNAGln2, but not for tRNA tRNAArg 




Development of a purification scheme for Pa-CD/Pa-Imm Complex 
 In order to perform structural studies and in vitro cleavage assays using purified Pa-CD, 
Pa-CD and Pa-Imm were cloned into an expression vector with multiple cloning sites (MSCs), 
pETDUET-1. Pa-Imm was successfully cloned into MCS2 and Pa-CD into MCS1 both with and 
without a His-tag. Attempts to grow cells containing pETDUET-1 plasmids with Pa-Imm in MCS1 
and Pa-CD in MCS2 were unsuccessful. This was the first indication that expression of MCS2 is 
higher than MCS1. Furthermore, when purifying the Pa-CD/Pa-Imm complex without a His-tag, 
it became obvious that there was a large amount of excess Pa-Imm in the sample which was not 
ideal for crystallization. The size difference between the complex (20 kDa) and the immunity 
protein alone (9 kDa) was too small to be separated effectively by size-exclusion chromatography. 
So therefore, I aimed to develop a purification scheme to not only separate Pa-CD/Pa-Imm 
complex from endogenous E. coli proteins but also from excess Pa-Imm which would likely act 
as an impurity during crystallization as all known toxin and immunity proteins bind in a 1:1 ratio 
heterodimer.  
 The most important step in the isolation of the Pa-CD/Pa-Imm complex from excess Pa-
Imm is the MonoQ portion. In the first two columns, DEAE and Heparin, there is no separation 
between the complex and the immunity protein alone. However, I observed that during MonoQ, 
excess Pa-Imm binds loosely to the column and is eluted early while most of the Pa-CD/Pa-Imm 
complex flows through the column (Figure 4.8, Lanes 2-4). However, if the flow is collected and 
run on MonoQ a second time, most of the Pa-CD/Pa-Imm complex will bind (Figure 4.8, Lanes 
6-10). The change in binding occurs without a change in salt content possibly because the excess 
Pa-Imm and endogenous E. coli proteins overload the MonoQ column on the first run. The 
resulting ratio after gel filtration (Figure 4.9) appears much closer to the 1:1 heterodimer which is 
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ideal for crystallization. Excess Pa-Imm is not an issue for the His-tag complex as the tag is on the 
toxin so excess immunity protein is lost after the Ni affinity column.  
Separation of Pa-CD from Pa-Imm 
Pa-CD and Pa-Imm form a very tightly bound complex which is typical of toxins and their 
immunity proteins. The addition of 6 M urea is not sufficient to denature the complex. Instead, a 
combination of 6 M urea and heating at 80 oC for 30 minutes must be used. Figure 4.10 shows the 
results of a typical denaturation process. Under denaturing conditions, Pa-CD flows through the 
MonoQ column (Lane 3) while Pa-Imm is retained (Lanes 5-10). Both proteins are refolded by 
stepwise dialysis to slowly get rid of urea.  The resulting proteins are both active in vitro.  
Crystallization of Pa-CD/Pa-Imm and solving for the phase 
 Crystals of the Pa-CD/Pa-Imm complex were obtained in sodium citrate solution with low 
pH and ammonium sulfate (Figure 4.11). These crystals diffracted well. However, crystals were 
only visible after eight or more months of hanging drop vaporization. This called into question 
whether the crystals were from Pa-CD/Pa-Imm complex, one of the two proteins which had 
dissociated from the other, or a protein impurity. The crystals were washed with well solution, 
then dissolved in SDS loading buffer, and SDS PAGE analysis showed the presence of both 
proteins in approximately 1:1 ratio though there does appear to be a portion of the toxin that is 
degraded (Figure 4.12, Lane 3).  
After confirming that the crystals contained the desired Pa-CD/Pa-Imm complex, we 
began trying to solve for the phase. Neither Pa-CD or Pa-Imm amino acid sequences contain a 
methionine residue outside of the start codon so our traditional method of seleno-methionine (s-
met) incorporation could not be used. Attempts at molecular replacement were unsuccessful. 
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Heavy atoms soaking was also tried but there were only enough crystals to trying soaking with 
two different solutions and neither were successful. Finally, I decided to mutate a few hydrophobic 
amino acids to methionine for s-met incorporation. The amino acids were chosen based on a 
sequence alignment of Pa-CD and Pa-Imm with toxins and immunity proteins predicted to be of 
the same family. Two hydrophobic residues with low conservation were chosen to be mutated in 
Pa-CD and in Pa-Imm (Figure 4.13). Three successful double mutations- Pa-CD-L22M/Pa-Imm-
L22M, Pa-CD-L22M/Pa-Imm-I36M, and Pa-CD-L22M-His6/Pa-Imm-L22M. These mutants 
were expressed and purified in the same manner as native complexes. Crystallization trays were 
set out using a screen containing the successful well solutions. Trays were set out at 18 oC as well 
as 25 oC with hopes to speed up the slow crystallization of Pa-CD/Pa-Imm. Unfortunately, at the 
time of this writing, crystals have not been obtained of the s-met complex and therefore, the 
phasing for the structure has not been solved.  
In vitro activity of Pa-CD and Pa-Imm 
 The in vitro activity of the refolded Pa-CD toxin was tested using tRNAGln1 as a substrate 
(Figure 4.14, left). This sample of Pa-CD was refolded in one step of dialysis (6M urea to 0M 
urea). The cleavage is not very efficient as it takes a ratio of 1:2 enzyme:substrate before significant 
cleavage product can be seen in 30 minutes which is poor turnover for a ribotoxin with its specific 
substrate. However, when Pa-CD is refolded in a stepwise manner, significant cleavage can be 
seen with a ratio of 1:10 or even 1:100 in only 10 minutes of reaction (Figure 4.15, Lanes 1-5). 
This is because stepwise refolding allows the protein to refold more slowly, supporting only the 
most favorable conformations. Pa-Imm, which likely has no catalytic activity, can completely 
inhibit Pa-CD activity even when refolded quickly (Figure 4.14, right). When Pa-CD cleavage 
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activity is compared to Colicin D, the two ribotoxins have comparable activity (Figure 4.15, Lanes 
1-5 vs Lanes 6-10).  
 To determine whether the activity and efficiency of refolded, recombinant Pa-CD is 
comparable to Pa-CD in vivo, more experimentation is required. In vitro Pa-CD reactions may be 
hindered by poor substrate quality, enzyme refolding, and buffer conditions. Additionally, there is 
evidence that some ribotoxins require other proteins as co-factors. The ribotoxin CdiA requires 
elongation factors, EF-Tu and EF-Ts, for its nuclease activity (123). CdiA must bind to the 
GTP·EF-Tu·aa-tRNA complex in order to cleave tRNA (124). EF-Ts increases CdiA’s turnover 
rate by promoting the formation of GTP·EF-Tu·aa-tRNA complexes, allowing for the target tRNA 
population to be brought more rapidly to the initiation complex where CdiA can cleave them. It is 
possible that Pa-CD also uses other proteins such as elongation factors to increase activity and 
turnover. Future studies will involve incubating Pa-CD with E. coli cell lysate to see if in vitro 
activity is increased.  
 In this study, we have identified and characterized a novel ribotoxin, Pa-CD.  We have 
shown that expression of Pa-CD in E. coli cells inhibits cell growth and that cell growth is not 
inhibited by co-expression of Pa-CD and Pa-Imm. The RNA targets of Pa-CD were confirmed by 
RNA-seq and northern blotting to be tRNAGln1, tRNAGln2, and tRNAHis. Pa-CD cleavage occurs 
between nucleotides 38 and 39 in the anticodon loop and results in 3’-P and 5’-OH termini. 
Furthermore, purification schemes have been developed for the purification of the Pa-CD/Pa-Imm 
complex and for the separation of that complex into functional Pa-CD and Pa-Imm proteins. 
Crystallization and mutagenesis studies have laid the groundwork for solving the structure of Pa-




4.4 Tables and Figures 
Pa-CD 










Figure 4.1. Amino acid sequences for Pa-CD and Pa-Imm. Only the toxic domain (highlighted in 

















Figure 4.2. E. coli codon-optimized Pa-CD and Pa-Imm inserts which were amplified from 




































Table 4.1. Primers for Quikchange mutagenesis. These primers were designed to mutate amino 












































Table 4.2. Sequences for in vitro transcription templates and primer and corresponding tRNAs. 
Templates and primer were purchased from IDT and gel purified. Each template was annealed to 
the primer and used in T7 RNA polymerase in vitro transcription reactions to polymerize the 






Figure 4.3 Inhibition of cell growth by Pa-CD. E. coli strain MG1655 was transformed with two 
plasmids- one with Pa-CD that is arabinose-inducible and the other with Pa-Imm which is ITPG-
inducible. Cultures were shaken at 37 oC until OD=0.5 then induced with water (black), IPTG 





Figure 4.4. Experimental design to use RNA-seq to identify RNA targets of novel ribotoxins. A) 
A sample of cellular RNA will contain RNAs with either triphosphate or monophosphate at the 5’ 
end. Exposure to a ribotoxin will introduce new 5’ends with either monophosphate or hydroxyl. 
B) RNA-seq method involves the ligation of a universal RNA adaptor to the 5’end of the RNAs. 
The 5’-P ligase will only be able to add the adaptor to RNAs with 5’-P. Comparison of the 







Figure 4.5. RNA-seq data of RNA cleavage by VapC20. Total RNA was extracted from 
VapC20 non-induced or induced cells. Data sets 3 (A) and 1 (B) (see Figure 4.4). C) The product 
of 3-1 indicates the cleavage site by VapC20. D) Zoomed in on the 23S rRNA gene. E) Structure 





Figure 4.6. RNA-seq data identifying the cleavage targets of Pa-CD. The difference between data 
sets 4 and 2 show cleavage products in tRNAHis (A), tRNAGln1 (B), and tRNAGln2 (C) as the result 
of Pa-CD expression. The site of cleavage is in the anticodon loop between bases 38 and 39 (D). 





Figure 4.7. Northern blotting for Pa-CD cleavage. tRNAs isolated from cells with (I) or without 
(NI) Pa-CD induction were used as substrates for Pa-CD cleavage. Products were analyzed by 
DPAGE followed by northern blotting with tRNA-specific P-32-labelled probes. FL indicates full 





Figure 4.8. MonoQ ion exchange for Pa-CD/Pa-Imm. In the first MonoQ, excess Pa-Imm is 
retained by the column while most of the complex is in the flow through (FT) (Lanes 2-4). 
Loading of the MQ1 FT onto MonoQ again results in retention of Pa-CD/Pa-Imm complex in 





Figure 4.9. Results of purification of Pa-CD/Pa-Imm complex. Lane 2 shows the final protein 
sample following purification by DEAE, Heparin, MonoQ (collect flow through), MonoQ 
(collect fractions) and Superdex-200 size-exclusion column. Lane 1 is the protein marker 






Figure 4.10. SDS PAGE of MonoQ of Pa-CD and Pa-Imm under denaturing conditions. Pa-
CD/Pa-Imm complex was denatured by adding 6 M urea and heating at 80 oC for 30 min. The 
resulting sample (Lane 2) was run on MonoQ with 6 M urea buffers. Pa-CD was eluted in the 
flow through (Lane 3) while Pa-Imm was retained by the column until eluted by salt gradient 
(Lanes 5-10). Lane 1 is protein maker.  
 
 







Figure 4.12. SDS PAGE analysis of Pa-CD/Pa-Imm crystals. Samples were run on 20% SDS 
PAGE to confirm the identity of the proteins observed in Pa-CD/Pa-Imm crystallization drops. 
1) Protein marker (bottom band is 10 kDa); 2) Purified Pa-CD-His/Pa-Imm complex; 3) Pa-
CD/Pa-Imm crystals were washed in well solution and dissolved in SDS loading buffer; 4) Pa-









Figure 4.13. Mutations for mutagenesis. Amino acid sequences for Pa-CD and Pa-Imm with the 
mutation points highlighted in yellow. Each highlighted amino acid was mutated to methionine for 







Pa-CD Mutation His-tagged? Pa-Imm Mutation 
L22M Yes L22M 
L22M Yes I36M 
L22M No L22M 
 






Figure 4.14. Activity test of Pa-CD and Pa-Imm. 2 µM tRNAGln1 was incubated with increasing 
concentrations of Pa-CD (0 µM, 0.1 µM, 0.25 µM, 0.5 µM ,1 µM) in Cleavage buffer for 30 
minutes at 37 oC (left). The same reactions were also carried out in the presence of equal 
concentration of Pa-Imm (right). The samples were denatured and run on 20% DPAGE gel. 






Figure 4.15. Comparison of the activities of Pa-CD and Colicin D. 10 µM tRNAGln1 (Pa-CD) or 
10 µM tRNAArg2 (Colicin D) were incubated with the indicated concentrations of toxin (µM) for 
10 minutes at 37 oC in Cleavage buffer. Samples were denatured and analyzed by 20% DPAGE. 
FL= full length tRNA, CL=Cleaved tRNA.  
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CHAPTER 5: PRELIMINARY INVESTIGATIONS OF RNA REPAIR COUPLED WITH 
RESCUE OF STALLED RIBOSOME BY RTCB2-PRFH 
 
5.1 Introduction  
 In 2011, RtcB was identified as the elusive 3’-P ligase activity capable of directly sealing 
2’,3’-cyclic phosphate and 5’-OH termini (65-67). RtcB proteins are widely distributed and have 
been discovered in eukaryotes, archaea, and bacteria. Eukaryotic and archaeal members of the 
RtcB superfamily have been demonstrated to be involved tRNA splicing. However, the 
biological role of this ligase in bacteria is largely unknown though many hypothesize that RtcB 
may be involved in RNA repair. During a genome-wide analysis, we found that Escherichia coli 
contains three distinct versions of RtcB, which we named RtcB1, RtcB2 and RtcB3, respectively 
(Figure 5.1 and Figure 5.2). E. coli RtcB1 has been reported to repair tRNA-like structures in 
vitro, to be expressed under conditions which inhibit the ribosome, and to reverse ribosome 
heterogeneity in MazF-treated cells (65,80,81). This data suggests that RtcB1 is involved in 
restoring protein synthesis following MazF-induced stress response.  
 Our lab is more interested in RtcB2 because this cluster is more distinct than RtcB1 and 
RtcB3 from the traditional RtcB of vertebrates and archaea which carry out tRNA splicing. 
Furthermore, in bacteria, RtcB2 is nearly always in the same operon as another conserved gene 
named protein release factor homolog (prfH) whose biological function is unknown. We 
constructed an SSN and Gene Neighborhood Network (GNN) for PrfH which confirmed that the 
reverse is also true (Figure 5.3 and Figure 5.4). We became interested in the pair-wise 
relationship between these two genes, whether they are functionally related, and what this 
relationship could tell us about the role of RtcB2 in bacteria.  
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 We performed a sequence alignment of PrfH with release factor 2 (RF2) (Figure 5.5). E. 
coli PrfH shares approximately 40% sequence identity with the central domains of E. coli RF2. 
Furthermore, the region involved in the hydrolysis of peptidyl-tRNA, including the catalytic 
GGQ motif, has the highest conservation (~80% sequence identity). This strongly suggests that 
PrfH is capable of hydrolyzing peptidyl-tRNA bonds in a manner similar to RF2.  
 RtcB has been revealed to be involved in RNA ligation and RtcB1 has been implemented 
in RNA repair; therefore, RtcB2 might also be an RNA repair enzyme. PrfH is likely capable of 
hydrolyzing peptidyl-tRNA bonds and is potentially functionally related to RtcB2. Therefore, we 
propose that PrfH and RtcB2 work in conjunction as a novel RNA repair pathway that rescues 
ribosomes stalled due to damaged rRNA or tRNA and then carries out RNA repair with the 
following hypothetical steps: 1) Protein translation is disrupted due to stalled ribosomes caused 
by RNA damage from ribotoxins; 2) PrfH binds to the stalled ribosomes and rescues them by 
peptidyl-tRNA hydrolysis; 3) RtcB2 repairs the damaged RNA; 4) Protein synthesis resumes. If 
our hypothesis is proven to be correct, we will have discovered a new pathway for ribosome 
rescue coupled with RNA repair.  
5.2 Materials and Methods 
General Materials and Methods 
 Plasmids for recombinant E. coli (Eco) RtcB2/pETDUET-1 and EcoRtcB1/pETDUET-1 
were provided by Dr. Pei Wang. Dr Wang also cloned EcoPrfH and Capnocytophaga gingivalis 
(Cg) PrfH into pETDUET-1 in constructs containing N-terminal or C-terminal His6 tags or no tag. 
Dr. Wang developed expression and purification protocols for EcoRtcB2, Eco and CgPrfH, and 
Eco and CgPrfH-His6. Plasmids were sequenced at the Roy J Carver center for Biotechnology. 
BL21 (DE3) competent cells were provided by Sandy McMasters at the cell media facility. 
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Development of ribosome purification technique was assisted by Dr. Fuxing Zeng in Dr. Hong 
Jin’s lab at UIUC.  
Expression and purification of EcoPrfH and CgPrfH 
 BL21 (DE3) cells (Invitrogen) were transformed with EcoPrfH/pETDUET-1 and CgPrfH/ 
pETDUET-1 with N-terminal or C-terminal His6 tags or without tags. Colonies were picked to 
inoculate small overnight cultures in LB with ampicillin 100 µg/mL at 37 oC. Overnight cultures 
were used to inoculate 1L LB with ampicillin 100 µg/mL. The cultures were shaken at 37 oC until 
OD=0.5 then induced with 500 µM IPTG and shaken at 37 oC for an additional four hours. The 
cells were harvested by centrifugation and the pellets were flash-frozen and stored at -80 oC.  
 All six proteins EcoPrfH, EcoPrfH-NHis, EcoPrfH-CHis, CgPrfH, CgPrfH-NHis, and 
CgPrfH-Chis were purified as described below (His tagged proteins do not bind His column). 2L 
cell pellets were resuspended in DEAE A and lysed by three passes through a French press at 1500 
psi. The supernatant was isolated by centrifugation. Recombinant PrfH was purified to homogeny 
by DEAE ion exchange (DEAE A and DEAE B), addition of 500 mM NaCl to the eluted fractions, 
and heparin affinity (DEAE A and DEAE B) chromatography. The protein was stored in 40% 
glycerol at -80 oC.  
Expression and purification of EcoRtcB1 and EcoRtcB2 
 EcoRtcB1/pETDUET-1 and EcoRtcB2/pETDUET-1 were transformed into BL21 (DE3) 
and starter cultures were made as described with PrfH. The starter cultures were used to inoculate 
1L LB with ampicillin 100 µg/mL. Cultures were shaken at 37 oC until OD=0.3 then were moved 
to shake at 18 oC until OD=0.4-0.6. Expression of the RtcB was induced by the addition of 200 
µM IPTG and the cultures were shaken at 18 oC for 14 hours. The cells were harvested by 
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centrifugation and the pellets were flash-frozen and stored at -80 oC. EcoRtcB1 and EcoRtcB2 
cells were resuspended in DEAE A buffer, lysed by French press, and centrifuged to isolate the 
supernatant. RtcB was purified by DEAE ion exchange (DEAE A and DEAE B) and heparin 
affinity (DEAE A and DEAE B) chromatography. Purified proteins were stored at -80 oC in 40% 
glycerol.  
Quikchange mutagenesis of PrfH 
 EcoPrfH-N-His6/pETDUET-1 and CgPrfH-N-His6/ pETDUET-1 plasmids were used as 
templates to produce catalytically inactive mutants. Primers (Table 5.1) were used to amplify 
mutant plasmids according to Quikchange site-directed mutagenesis protocol (Stratagene). The 
mutated plasmids were confirmed by DNA sequencing, transformed into BL21 (DE3), and 
expressed and purified in the same way as WT.  
Isolation of 70S, 50S, 30S and polysome mixture using centrifugation and FPLC 
 E. coli strain MRE600 cells (ATCC) were grown in LB at 37 oC until OD600= 0.4-0.5. The 
cells were harvested by centrifugation. Pellets were washed, flash-frozen and stored at -80 oC. To 
begin ribosome purification, cell pellets were resuspended in RP-A (20 mM HEPES pH 7.5, 0.1 
M NH4Cl, 10.5 mM MgCl2, 0.5 mM EDTA, and 0.5 mM PMSF) (1.5 mL RP-A/1 g cell paste). 
The cells were lysed by three passes through the French press at 1500 psi. DNase I (5.5 µg/mL) 
was added and the soluble portion of the lysate was isolated by centrifuging for 40 minutes at 
20,000 rpm then centrifuging the resulting supernatant again for 5 minutes at 13,200 rpm.  
 The supernatant was loaded onto 18 mL of sucrose cushion made of RP-B (1.1 M sucrose, 
20 mM HEPES pH 7.5, 1.0 M NH4Cl, 10.5 mM MgCl2, and 0.5 mM EDTA) in 26.3 mL 
polycarbonate centrifuge bottles (Beckman Coulter, 355618). The tubes were placed in a type 60 
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TI rotor (125) and centrifuged in an Optima XE-90 Ultracentrifuge (125) for 18.5 hours at 40,000 
rpm and 4 oC. After centrifugation, the supernatant was poured off and the pellets were washed 
with RP-A. The pellets were gently resuspended in RP-C (20 mM HEPES pH 7.5, 1.5 M NH4SO4 
and 10 mM MgCl2) (10 mL volume/1.2 g cell paste. 10 mL crude ribosomes in RP-C was loaded 
onto a 5 mL Butyl650S hydrophobic column and eluted by RP-D (20 mM HEPES pH 7.5 and 10 
mM MgCl2). The ribosomes were concentrated as desired in 100K centricons (Millipore) and 
stored in -80 oC.   
Separation 70S, 50S, and 30S subunits using centrifugation 
 MRE600 cells were grown, lysed, and centrifuged for 18.5 hours in a type 60 Ti rotor as 
described above with the exception that the cells were resuspended in Lysis buffer (20 mM HEPES 
pH 7.5, 30 mM NH4Cl, 6 mM MgCl2, and 4 mM β-mercaptoethanol) and centrifuged on a sucrose 
cushion containing Lysis buffer and 1.1 M sucrose. After the initial centrifugation, pellets were 
washed and resuspended in either Lysis buffer for 70S purification or Dissociation buffer (20 mM 
HEPES pH 7.5, 200 mM NH4Cl, 1 mM MgCl2, and 4 mM β-mercaptoethanol) for 50S and 30S 
purification. Ribosomes were centrifuged for 5 minutes at 13,200 rpm. The supernatant was loaded 
onto 14 mL 2-20% sucrose gradients made out of Lysis or Dissociation buffer. The gradients were 
centrifuged in a SW-41 swinging bucket rotor (125) for 14 hours at 20,000 rpm and 4 oC. After 
centrifugation, the gradients were fractionated into 0.7 mL fractions using an ÄKTA Pure 
chromatography system (GE).  
Filtration bindings assays 
 Ribosome mixture of 70S, 50S, 30S and polysomes isolated as described above were buffer 
exchanged to RP-A buffer after Butyl650S purification. Reactions were set up containing 2 µM 
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ribosomes and 4 µM EcoPrfH, CgPrfH, or Pa-Imm in 40 µL RP-A buffer. Reactions were 
incubated at 37 oC. 0.5 mL 100K centricons were equilibrated with RP-A buffer. After incubation, 
the reactions were added to the centricons and centrifuged for 8 minutes at 8,000 rpm. Flow 
through was collected. The columns were washed two times by addition of 40 µL RP-A and 
centrifugation for 8 minutes at 8,000 rpm. After the second wash, the columns were centrifuged at 
8000 rpm until 20 µL remained. An additional 20 µL RP-A was added and the samples were 
recovered from the column by inverting and centrifuging. 3 µL each sample was run on 20% SDS 
PAGE. Proteins were transferred to a membrane for 2 hours and 20 minutes at 300 mAmps. The 
membrane was incubated in blocking buffer for 1 hour. The membrane was incubated with mouse 
anti-His antibody (GE) for one hour, washed three times in PBS buffer for 5 min, incubated for 
one hour in rabbit anti-mouse-HRP-conjugated antibody, and was three times for 15 minutes. 
Clarity ECL solutions (Biorad) was used to visualize the antibody. 
Binding assays using ultracentrifugation 
 Ribosome mixture of 70S, 50S, 30S and polysomes was isolated by lysis and centrifugation 
in Lysis buffer as previously described. After the initial centrifugation, pellets were resuspended 
in either Lysis or Dissociation buffer and centrifuged 5 minutes at 13,200 rpm. 200 µL reactions 
containing 0.62 µM ribosome and 2 µM EcoPrfH in Lysis or Dissociation buffer. Binding reactions 
were incubated 15 minutes at 37 oC then loaded onto 5-20% sucrose gradients in Lysis or 
Dissociation buffer. 70S, 50S, and 30S subunits were isolated by centrifugation and fractionation 
as described above. The half of the 0.7 mL (350 µL) fractions was concentrated to 30 µL by TCA 
precipitation. 5 µL of each sample was run on 20% SDS PAGE and analyzed by western blotting 
in the same way as the filtration binding assay samples.  
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EcoRtcB1 and EcoRtcB2 repair assay 
 The two halves of the RNA substrate, Arg-38 and Arg-22, were designed to mimic tRNAArg 
ΔT. Arg-38 and Arg-22 were annealed together by heating 3 min at 95 oC then cooling slowly to 
25 oC. Reactions containing 10 µM Arg-38/Arg-22, 8 µM RtcB1 or RtcB2, and 10 mM GTP in 
RtcB ligation buffer (50 mM Tris-HCl pH 7.4, 2 mM MgCl2, and 2 mM MnCl2) were incubated 
for one hour at 37 oC. 6 µL of each reaction mixture was removed at t=0, 15, 30, and 60 min. 
DPAGE loading buffer was added and the samples were denatured by heating for 3 min at 95 oC. 
Samples were run on 20% DPAGE gel and RNA was visualized by methylene blue staining.  
5.3 Results and Discussion 
Bioinformatic analysis of RtcB and PrfH 
 The SSN of the RtcB superfamily shows four distinct clusters of nodes (Figure 5.1). E. coli 
contains three copies of RtcB, one from each cluster 1, 2, and 3. RtcB1 has been shown to be 
involved in the response to MazF-induced ribosome heterogeneity. RtcB3 is most closely related 
to HsaRtcB which is the tRNA splicing ligase so the substrate for RtcB3 is likely be tRNA. Our 
lab is most interested in RtcB2 which is more distinct from the other clusters, has a smaller size 
range which could indicate that it works within a confined space such as the ribosome, and is 
almost always associated with PrfH. 
 Figure 5.3 shows SSNs of RtcB2 and PrfH and their distribution among bacterial phylum. 
Most phylum contain both proteins while Bacteroidetes contains only PrfH and RtcB2 is found in 
a small number of eukaryotes. Furthermore, a GNN of PrfH showed that in 9 of the 12 PrfH clusters 
at least 50% of nodes were found within five genes or less of RtcB2 (Figure 5.4). Sequence 
alignment of EcoPrfH with EcoRF2 showed that they shared 40% sequence identity. A more in-
103 
 
depth sequence alignment showed that the catalytic GGQ motif which is responsible for the 
hydrolysis of the nascent peptide chain is also highly conserved in PrfH sequences (Figure 5.5). 
This bioinformatic analysis led us to hypothesize that PrfH is capable of hydrolyzing peptidyl-
tRNA bonds and therefore, we expect PrfH binds to the ribosome.  
PrfH binds to E. coli ribosomes 
 To test whether PrfH binds to the ribosome, we developed two methods- filtration binding 
assays and centrifugation binding assays. The schematic for the filtration assay is shown in Figure 
5.8. This assay relies upon the large size of the ribosome. If PrfH is bound to the ribosome, it will 
not pass through the 100 kDa-sized pores of the centricon; however, any PrfH that is not ribosome-
bound should pass the pores and be present in the flow through. The results for a filtration binding 
assays showed that PrfH does bind to or at least interacts with the ribosome (Figure 5.9). The 
amount of PrfH that was in the centricon before centrifugation (B) can be compared to the amount 
that was retained in the centricon after centrifugation and washing (R) and the amount that flowed 
through (F). CgPrfH was not retained by the centricon on its own (Figure 5.9, Lanes 2 vs 3) but 
was retained in the centricon with the ribosome (Figure 5.9, Lanes 2 vs 4). For EcoPrfH, a small 
amount of protein was retained in the absence of the ribosome (Figure 5.9, Lanes 5 vs 6) and a 
much larger portion of protein was retained in the presence of the ribosome (Figure 5.9, Lanes 5 
vs 7).  
 Filtration assays were a good way to perform an initial test for binding between PrfH and 
the ribosome. However, there were shortcomings. First, the intensity of PrfH that was retained plus 
the intensity that flowed through the centricon did not usually add up with the intensity of the 
before sample. Furthermore, in reaction the reaction described above, PrfH was in a two-fold 
excess over the ribosome so if PrfH binds to the ribosome in a 1:1 ratio like we suspect, half of the 
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protein should be in the flow through. Yet, this was not what we observed. One possibility for the 
discrepancy is that the ribosome blocks the pores so that unbound PrfH cannot flow through. 
Additionally, Pa-Imm-His6 was used as a negative control. Pa-Imm-His6 was observed in the 
before sample (Figure 5.9, Lane 8) and not observed in the retained sample with or without 
ribosomes which was our expectation (Figure 5.9, Lanes 9 and 10). However, there was also only 
a small amount of protein in the flow throughs (Figure 5.9, right blot, Lanes 6 and 7). The protein 
was lost somewhere in the centricon possibly trapped in the pores. These results indicate that while 
it is likely that PrfH does bind to the ribosome, this assay is not the most effective means of 
measuring this binding.  
 The limitations of the filtration binding assays led me to design a binding assay using 
ultracentrifugation. Ribosome samples containing a mixture of 70S, 50S, 30S, and polysomes were 
incubated with EcoPrfH under conditions which allowed for subunit association (Lysis buffer) or 
subunit dissociation (Dissociation buffer). The samples were then loaded onto sucrose gradients 
in the corresponding buffer and centrifuged to separate the 70S, 50S, and 30S subunits into 
fractions (Figure 5.10). For association conditions, the FPLC UV tracing showed a major peak for 
70S and small peaks for excess 50S and 30S. In dissociating conditions, two peaks, 50S and 30S, 
were observed. Western blotting analysis was used to probe for PrfH in each fraction (Figure 5.11). 
In association conditions, EcoPrfH was found in the fractions containing the 70S peak (Figure 
5.11, top, Lanes 5-10) indicating that EcoPrfH was bound to the intact ribosome. Under 
dissociation conditions, only non-specific binding of the antibody to ribosomal proteins was 
observed (Figure 5.11, bottom, Lanes 2-10). EcoPrfH may not bind to the dissociated 50S and 30S 
or the conditions in this experiment may not be favorable for binding. Further experimentation is 
required hopefully with the use of an antibody that is specific for PrfH rather than His-tag.   
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EcoRtcB2 is inefficient at repairing tRNA-like substrates 
 The repair activity of EcoRtcB1 and EcoRtcB2 on a tRNA-like structure was tested for 
comparison. Two synthetic RNA substrates, Arg-38 and Arg-22, were annealed together to form 
a tRNAArg -like substrate that was missing its T loop and which had been cleaved between 
nucleotides 38 and 39 such as in the case of colicin D cleavage (tRNAArgΔT) (Figure 5.12, left). A 
time course repair reaction was carried out with both RtcB. After one hour, RtcB1 repaired the 
substrate efficiently (Figure 5.12, right, Lanes 1-4). On the other hand, RtcB2 only repaired 
approximately 20% of the substrate in the same time frame (Figure 5.12, right, Lanes 5-8). This 
result indicates that the in vivo substrate for RtcB2 is not a tRNA.   
Potential role of PrfH-RtcB2 in ribosome rescue and repair 
 The results presented here, while preliminary, are consistent with our hypothesis that PrfH 
and RtcB2 work together to carry out ribosome rescue and RNA repair. Our results have shown in 
two ways that EcoPrfH binds to the 70S ribosomal subunit. This is consistent with PrfH acting as 
a release factor to enter a stalled ribosome and dissociate the subunits. Under canonical translation 
termination, RF1 and RF2, recognize that the ribosome has encountered a stop codon (Figure 5.13, 
left) (126). RF enters the A site and performs peptidyl-tRNA hydrolysis, which releases the peptide 
and allows the subunits to dissociate. In some situations, the ribosome can become stalled on a 
“non-stop” mRNA which has ended without a stop codon (Figure 5.13, center). Three ribosome 
rescue mechanisms have been identified which rectify this situation: trans-translation (127,128), 
ArfA (125,129), and ArfB (130). However, a third situation could arise wherein, there is still 
readable mRNA in the A site but the ribosome has stalled for another reason, for example rRNA 
is damaged and elongation cannot continue or the cognate tRNA to the codon in the A site has 
been depleted (Figure 5.13, right). Both of these examples could be the result of ribotoxin damage. 
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We propose that PrfH acts as a rescue system in this scenario and that the role of RtcB2 is to repair 
the damaged RNA which had caused the ribosome to stall. Based on our report, that RtcB2 is 
ineffective at repairing tRNA-like structures, it is possible that the in vivo target of RtcB2 repair is 
ribosomal RNA.  
5.4 Table and Figures 
 
 
Figure 5.1. Sequence Similarity Network (SSN) of RtcB in all domains of life. Each node (colored 
circle) represents RtcB sequences that share >95% sequence identity. Nodes are connected by 
edges (gray lines) if the E-value measuring the sequence similarities is less than E=1x10-40. E. coli 
has three RtcB, each in a different cluster of nodes (orange arrows). Human RtcB is labeled with 











Figure 5.3. SSN of RtcB2 and SSN of PrfH. (A) Sequences of RtcB2 cluster from Figure 5.1 were 
used to create a new SSN with 95% representative nodes and E-value=1x10-80. (B) SSN of PrfH 
with 95% representative nodes and E-value=1x10-40. Nodes are colored based on phylum with the 








Figure 5.4. Bioinformatic analysis of PrfH present in bacteria. (A) SSN of PrfH with each node 
(colored circle) representing sequences with >95% identity. Nodes are connected by edges if the 
E-value between them is smaller than the cutoff value of E=1x10-45. EcoPrfH and CgPrfH are 
marked with a number sign and asterisk, respectively. (B) Gene Neighborhood Network (GNN) 
made from the SSN in (A). Each cluster in A is represented by the same color shape. A cluster is 
connected to a neighboring gene (white hexagon) if at least 50% of nodes within that cluster 







Figure 5.5. Sequence alignment of PrfH and RF2. EcoPrfH and EcoRF2 share 40% sequence 



















EcoPrfH   --MILLQLSSAQGPEECCLAVRKALDRLIKEATRQDVAVTVLETETGRYSDTLRSALISLDGDNAWALSESWCGTIQWICPSPYRPHHGR
SenPrfH   --MILLQLSSAQGPDECCLAVKKALDCLTKEAAREKVSLTRLETEPGRLPDTLRSALVSLDGEKAMAFSERWCGTLLWICTSPYRPHHGR
PaePrfH   --MILLQLSAAQGPAECCLAVAKAFERLCLEAAQAGVEVEVIEEVAGERPRTWRSLLLGLRGTAAEALAERWCGGIQWICPSPYRARHAR
CgiPrfH   MEEKIIQITAGRGPLECQWVVAKVLKTFLQEATQAGISYTILSREEGDANLTVKSVTLQLKGKELASFLKTWLGTVCWVGKSTFRKFHQR
EcoRF2    SADCYLDIQAGSGGTEAQDWASMLERMYLRWAESRGFKTEIIEESEGEVAG-IKSVTIKISGDYAYGWLRTETGVHRLVRKSPFDSGGRR
SenRF2    SADCYLDIQAGSGGTEAQDWASMLLRMYLRWAEARGFKTEVIEESEGEVAG-IKSATIKISGEYAYGWLRTETGVHRLVRKSPFDSGGRR
PaeRF2    PNNAYLDIQAGSGGTEAQDWANMLLRMYLRWADKHGFDATIIELSEGEVAG-IKGATVHIKGEYAFGWLRTEIGVHRLVRKSPFDSGNRR
CgiRF2    ALSAVLQITAGAGGTESCDWASMLMRMYMMWANRQGFSVKELNFQEGDVAG-VKTVTLEIDGEFAFGYLKGENGVHRLVRISPFDSNAKR
consensus ----llqisag-G-tEc-dw---llrmylk-A-r-gf-vtvle--eGevagtlksati-l-Geyawgflkt--Gvhr-vrkSpf-s-hrR
EcoPrfH   KNWFLGIGRFTADEQEQSDA-----IRYETLRSSGPGGQHVNKTDSAVRATHLASGISVKVQSERSQHANKRLARLLIAWKLEQQQQENS
SenPrfH   KNWYVGIGRFSADEHIQSDE-----IRFETLRSSGPGGQHVNKTDSAVRATHLASGISVKVQSERSQHANKRLARLLIAWRLEQQRQNEC
PaePrfH   KNWFIGAERFAAPPASLEGE-----IRFETLRSSGPGGQHVNTTDSAVRATHLASGISVRVQSQRSQHANKRLAILLIARRLADQASSAA
CgiPrfH   SNWYIGVFELDQLQRQLFSER---DVQFQTTRSQGNGGQNVNKVNSAVRATHLPTGISVLAQDSRSQLDNKKLALARLKEKLAEMELQQL
EcoRF2    HTSFSSAFVYPEVDDDIDIEINPADLRIDVYRASGAGGQHVNRTESAVRITHIPTGIVTQCQNDRSQHKNKDQAMKQMKAKLYELEMQKK
SenRF2    HTSFSSAFVYPEVDDDIDIDINPADLRIDVYRASGAGGQHVNRTESAVRITHIPTGIVTQCQNDRSQHKNKDQAMKQMKAKLYELEMQKK
PaeRF2    HTSFTAVFVSPEIDDNIEIEINPADLRIDTYRSSGAGGQHVNTTDSAVRITHVPTNTVVACQNERSQHANKDTAMKMLRAKLYELEMQKR
CgiRF2    HTSFASVYVYPLADDTIEIEINPADISFETMRSSGAGGQNVNKVETAVRLRHHPTGIIIENSETRSQLDNKNKALQLLKSQLYEIELKKR
consensus h--flgifvfp-ldd-ieieinpadirfetlRssGaGGQhVNktdsAVRatHlptgisv--q-eRSQhaNKrlAi-lik-kLyemelqkk
EcoPrfH   AALKSQRRMFHHQIERGNPRRTFTGMAFIEG
SenPrfH   AALKSERRLFHHQIERGNPLRIFKGMAF---
PaePrfH   DALRAERRRAHGRISRGAARRVFRGERFEPA
CgiPrfH   AEQAQNHWNNHTQVQRGNPVRTFKGTDFKST
EcoRF2    NAEKQAMEDNKSDIGWGSQIRSYVLDDSR--
SenRF2    NAEKQAMEDTKSDIGWGSQIRSYVLDDSR--
PaeRF2    TAASQALEDSKSDIGWGHQIRSYVLDQSR--




>gb|ASHD01000042.1|:18981-19595 Escherichia coli ATCC 25922 ATCC_contig_45, whole 













>gb|ACLQ01000014.1|:39362-40057 Capnocytophaga gingivalis ATCC 33624 















Figure 5.6. Sequences for EcoPrfH and CgPrfH that were cloned into pETDUET-1 vector. The 
















>644450368 ZP_04057207 putative peptide chain release factor H [Capnocytophaga gingivalis 




































Table 5.1. Primers for Quikchange mutagenesis. The Q of the GGQ motif was mutated to E and 
to N. The nucleotides that were mutated are highlighted in yellow while the rest of the Q codon is 





Figure 5.8. Schematic representation of filtration binding assays. PrfH and ribosomes are 
incubated together to allow for binding. The samples are loaded into 100K centricons and 
centrifuged so that any PrfH not bind to a ribosome should pass through the pores of the column. 
The column is washed to remove unbound PrfH. Then the retained sample is recovered by 




Figure 5.9. Western blot analysis of a filtration binding assay. Reactions were as follows: 1) 70S 
only (data not shown); 2) CgPrfH only; 3) 70S and CgPrfH; 4) EcoPrfH only; 5) 70S and 
EcoPrfH; 6) Pa-Imm only; and 7) 70S and Pa-Imm.  Pa-Imm-His6 was used as a negative 
control. B= sample collected before centrifugation, R= retained sample after centrifugation, F= 





Figure 5.10. UV tracings of the separation of 70S, 50S, and 30S subunits. (A) Result of 
fractionation of ribosomes in sucrose gradient made from Lysis buffer. (B) Result of 
fractionation of ribosomes in sucrose gradient made from Dissociation buffer. These particular 
gradients were from the experiment described in Figure 5.11. Peaks containing 70S, 50S, and 





Figure 5.11. Results of an ultracentrifugation binding assay. EcoPrfH and a mixture of 70S, 50S, 
30, and polysomes were incubated together and then centrifuged on 5-20% sucrose gradients in 
either Lysis or Dissociation buffer to separate 70S, 50S and 30S. The gradients were divided into 
fractions by FLPC. The fractions containing the highest UV (see Figure 5.10) were analyzed by 
western blotting. L= loading sample 
 
 
Figure 5.12. Repair of tRNA-like structure by RtcB1 and RtcB2. A substrate designed to mimic 
tRNAArgΔT cleaved by colicin D (left) was repaired by EcoRtcB1 or EcoRtcB2 (right). F= full 





Figure 5.13. Mechanisms for peptidyl-tRNA release and ribosome dissociation. (A) Schematic 
view of canonical translation termination. The ribosome has encountered a stop codon (red) in 
the A site. RF1 or RF2 recognizes the stop codon, releases the peptide, and dissociates the 
ribosome. (B) The ribosome is stalled because it has encountered a “non-stop” mRNA which has 
ended without a stop codon. The A site is empty of mRNA so another tRNA or RF will not be 
brought in for codon recognition. In this case, the ribosome can be rescued by trans-translation, 
ArfA, or ArfB. (C) There is still mRNA in the A site, but the ribosome is stalled for another 
reason such as damaged rRNA or depletion of the needed tRNA due to ribotoxin exposure. We 






CHAPTER 6: CONCLUSIONS AND SUMMARY 
 
6.1 Summary of RNA damage and repair 
 RNA is susceptible to damage due to its 2’-OH which can conduct a nucleophilic attack 
on the phosphate backbone, resulting in cleavage. Many organisms take advantage of the 
vulnerability of RNA by employing ribotoxins which cleave RNAs that are necessary for 
translation- rRNAs, tRNAs, and mRNAs. The use of ribotoxins allows cells to kill other 
organisms competing for the same resources or to respond to intracellular stresses such as 
nutrient deficiency or invasion by a virus. RNA damage can be reversed by RNA repair systems 
which can reseal RNA using either 5’-P or 3’-P ligation. A few RNA repair systems have been 
identified in vitro and many more have been identified in silico; however, it is challenging to 
identify the targets of these RNA repair systems in vivo due to the added complication of cellular 
nucleases and ligases and typical RNA cleavage and degradation. One approach that our lab has 
taken to study RNA repair is to instead study proteins which are associated with RNA repair 
systems, such as RlaP-NTase and PrfH, and ribotoxins which carry out RNA damage, such as 
Pa-CD. Our aim in studying proteins associated with RNA repair is to elucidate the functions of 
these proteins and how/if they are functionally related to their corresponding RNA repair 
systems. The purpose in studying ribotoxins is to learn more about the targets and mechanisms of 






6.2 Conclusions for RlaP-NTase 
 Nucleotidyltransferases (NTases) of Pol superfamily are highly diverse and play many 
important biological functions. However, the biological functions of many families of NTases 
remain unknown. A recent bioinformatic study named some members of PF10127 family as 
RlaP (RNA ligase-associating Pol) NTases, due to physical proximity of the genes encoding 
these NTases with various RNA ligases. Here we report a comprehensive characterization of two 
recombinant RlaP-NTases. Our study showed that, among macromolecules isolated from E. coli 
cells, only RNAs are substrates of RlaP-NTase. In vitro assays employing two synthetic RNAs as 
substrates revealed that RlaP-NTase catalyzes addition of one or two NMP to the 3’-hydroxyl 
group of RNA substrates, and the reactions exhibit a preference for RNA substrates resulting 
from RNA damage by ribotoxins.  
 The crystal structure of PfRlaP-NTase provided insight into folding of NTases of the 
PF10127 family. Aminoacylation assays demonstrated that RlaP-NTase is required to restore 
biological function of repaired tRNAs that have experienced excessive damage. Collectively, we 
propose an in vivo scenario that cell survival requires the involvement of RlaP-NTase in RNA 
repair, where a direct repair of an excessively damaged RNA is not sufficient to restore the 
biological function of the RNA (Figure 2.15). In the future, our lab is interested in more in-depth 
functional RlaP-NTase assays. We are also interested in studying other RlaP-NTases such as 
those which are associated with 5’-P ligases. Preliminary investigations of a viral RlaP-NTase 





6.3 Conclusions for Pa-CD 
 Pa-CD and Pa-Imm were first identified via bioinformatics as a polymorphic toxin 
system predicted to behave similarly to colicin D and its immunity protein. We report that Pa-
CD is a potent toxin which inhibits cell growth and Pa-Imm inhibits the toxic activity of Pa-CD. 
Using both RNA-seq methodology and northern blotting analysis, the RNA targets for Pa-CD 
were determined to be E. coli tRNAGln1, tRNAGln2, and tRNAHis. The site of excision is in the 
anticodon loop between nucleotides 38 and 39, the same site as colicin D. Cleavage results in 5’-
OH termini at the 3’-half which is characteristic of most known ribotoxins. Finally, though the 
crystal structure of the Pa-CD/Pa-Imm complex was not solved, the data presented here includes 
a protocol for the purification and successful (but slow) crystallization of Pa-CD/Pa-Imm and 
the production and generation of double mutants for incorporation of s-met into the complex 
crystals. Future work entails using the methods outlined here to obtain s-met Pa-CD/Pa-Imm 
crystals and solve to phase to complete the structure and testing Pa-CD activity with E. coli cell 
lysate to determine if another protein cofactor is present which increases activity.  
6.4 Conclusions for RtcB2-PrfH 
 Preliminary studies have investigated the pair-wise relationship of RtcB2 and PrfH. 
Bioinformatic analysis using SSNs and GNNs showed that bacterial RtcB2 is nearly always 
within five genes of PrfH and that the reverse is true for PrfH. In two different binding assays, 
PrfH bound to the ribosome, specifically the 70S subunit. Data for 30S and 50S subunits was not 
conclusive. Finally, EcoRctB2 was shown to be ineffective at repairing tRNA-like substrates 
indicating that tRNA may not be the endogenous substrate for RtcB2. These initial results are by 
no means conclusive, but they are consistent with our hypothesis that PrfH and RtcB work 
together to rescue stalled ribosomes and repair damaged RNA. Future studies concerning RtcB2 
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and PrfH will not be discussed here as this work is currently being undertaken by another student 
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